fluorouracil has been researched along with Uterine Cervical Neoplasms in 430 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the efficacy and tolerability of combination therapy with capecitabine and cisplatin in patients with recurrent carcinoma of the uterine cervix." | 9.12 | A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix. ( Benjapibal, M; Inthasorn, P; Leelaphatanadit, C; Therasakvichya, S; Thirapakawong, C, 2007) |
| "The goal of this work was to evaluate response rate, toxicity, and survival in treatment with intraarterial 5-fluorouracil (5-FU) and cisplatin in a neoadjuvant setting; this combination was administered to patients with locally advanced cervical adenocarcinoma." | 9.09 | Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma. ( Aoki, Y; Sasaki, M; Sato, T; Tanaka, K; Tsuneki, I; Watanabe, M, 2001) |
| "The objective of the study was to determine the response rate and associated toxicity of 5-fluorouracil and high-dose leucovorin in patients with recurrent adenocarcinoma of the cervix." | 9.08 | Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study. ( Andersen, WA; Blessing, JA; Look, KY; Manetta, A; McGehee, R; Valea, FA; Webster, KD, 1997) |
| "On the strength of recent evidence of the activity of the combination of cisplatin and 5-fluorouracil against squamous malignancies of the esophagus and head and neck, this regimen was evaluated in a phase II trial against metastatic or recurrent squamous carcinoma of the uterine cervix." | 9.06 | A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial. ( Alberts, DS; Boutselis, JG; Green, S; Hannigan, EV; Surwit, EA; Wallace, DL; Weiss, GR, 1990) |
| "Low-dose consecutive intra-arterial infusion therapy with cisplatin and 5-fluorouracil as neoadjuvant chemotherapy was performed on 3 cases of cervical adenocarcinoma (two stage IIb and one stage IIIb)." | 7.69 | [Three cases of uterine cervical adenocarcinoma successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil)]. ( Narimatsu, A; Okada, O, 1996) |
| "Local treatment with 5% of 5-Fluorouracil (5-Fu) in the form of globules was carried out on 37 patients with carcinoma in situ of the uterine cervix, established histologically, as the application was performed once daily for a period of 14-20 days." | 7.68 | [The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil]. ( Chakalova, G; Karag'ozov, A; Marinova, L; Ralcheva, Ts, 1991) |
| "Forty patients with locally advanced cervical carcinoma were entered into a protocol utilizing the bolus administration of both mitomycin C (10 or 15 mg) on Day 1 and 5-fluorouracil (400 mg) on Day 1-5 followed by sequential pelvic irradiation on Day 6 between September 1980 and October 1985." | 6.18 | Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer. ( Breen, JL; Denehy, TR; Eastman, R; Gregori, CA; SanFilippo, L, 1996) |
| "To assess the efficacy and tolerability of combination therapy with capecitabine and cisplatin in patients with recurrent carcinoma of the uterine cervix." | 5.12 | A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix. ( Benjapibal, M; Inthasorn, P; Leelaphatanadit, C; Therasakvichya, S; Thirapakawong, C, 2007) |
| "The goal of this work was to evaluate response rate, toxicity, and survival in treatment with intraarterial 5-fluorouracil (5-FU) and cisplatin in a neoadjuvant setting; this combination was administered to patients with locally advanced cervical adenocarcinoma." | 5.09 | Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma. ( Aoki, Y; Sasaki, M; Sato, T; Tanaka, K; Tsuneki, I; Watanabe, M, 2001) |
| "The objective of the study was to determine the response rate and associated toxicity of 5-fluorouracil and high-dose leucovorin in patients with recurrent adenocarcinoma of the cervix." | 5.08 | Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study. ( Andersen, WA; Blessing, JA; Look, KY; Manetta, A; McGehee, R; Valea, FA; Webster, KD, 1997) |
| "On the strength of recent evidence of the activity of the combination of cisplatin and 5-fluorouracil against squamous malignancies of the esophagus and head and neck, this regimen was evaluated in a phase II trial against metastatic or recurrent squamous carcinoma of the uterine cervix." | 5.06 | A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial. ( Alberts, DS; Boutselis, JG; Green, S; Hannigan, EV; Surwit, EA; Wallace, DL; Weiss, GR, 1990) |
| "At this juncture in the development of paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ), knowledge about the agent's pharmacologic behavior and clinical antitumor activity in less common neoplasms is being elucidated." | 4.79 | Paclitaxel pharmacology and other tumor types. ( Rowinsky, EK, 1997) |
| " In the present study, we evaluated ERCC1 expression levels in uterine cervical adenocarcinoma cell lines to assess whether they are affected by treatment with cisplatin with and without 5-fluorouracil (5-FU)." | 3.80 | ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells. ( Fujii, T; Hasegawa, K; Kato, R; Minami, Y; Torii, Y; Udagawa, Y, 2014) |
| ") on sensitivity to chemotherapeutic agents, paclitaxel and doxorubicin as MDR1/P-glycoprotein substrates, and cisplatin and 5-fluorouracil as non-substrates, in human cervical carcinoma HeLa cells, and paclitaxel-resistant and cisplatin-resistant derivatives (HeLa/TXL and HeLa/CDDP, respectively)." | 3.74 | Effects of Agaricus blazei Murill extract on sensitivity to chemotherapeutic agents in HeLa cells and its resistant sublines. ( Kitada, N; Obata, Y; Ohnishi, N; Shin, Y; Takara, K; Yokoyama, T, 2008) |
| "We retrospectively reviewed 47 patients with locally advanced or bulky cervical carcinoma treated with two courses of intraarterial infusion of cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil (5-FU), followed by radical hysterectomy at our hospital between 1988 and 1995." | 3.70 | Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma. ( Kataoka, N; Konishi, I; Mandai, M; Mori, T; Nagata, Y; Nanbu, K; Tsuruta, Y, 1998) |
| "Low-dose consecutive intra-arterial infusion therapy with cisplatin and 5-fluorouracil as neoadjuvant chemotherapy was performed on 3 cases of cervical adenocarcinoma (two stage IIb and one stage IIIb)." | 3.69 | [Three cases of uterine cervical adenocarcinoma successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil)]. ( Narimatsu, A; Okada, O, 1996) |
| "We have investigated the effects of 5-fluorouracil (5-FU) on cell growth, DNA synthesis, morphological changes, DNA fragmentation and Fas antigen expression of cultured human uterine cervical carcinoma cells (OMC-1 squamous-cell carcinoma and OMC-4 adenocarcinoma)." | 3.69 | Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil. ( Inoki, C; Kumagai, K; Orino, I; Ueda, M; Ueki, K; Ueki, M, 1997) |
| " 5-Fluorouracil (5-FU) was effective against only one bladder cancer xenograft among 6 cancer xenografts tested." | 3.68 | [Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice]. ( Adachi, S; Akaza, H; Ishitsuka, H; Kanazawa, K; Miwa, M; Nitta, K; Sekiguchi, F; Tokita, H, 1991) |
| "Local treatment with 5% of 5-Fluorouracil (5-Fu) in the form of globules was carried out on 37 patients with carcinoma in situ of the uterine cervix, established histologically, as the application was performed once daily for a period of 14-20 days." | 3.68 | [The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil]. ( Chakalova, G; Karag'ozov, A; Marinova, L; Ralcheva, Ts, 1991) |
| "50 patients with recurrent cervical carcinoma were included in a phase II study of cisplatinum and 5-fluorouracil." | 3.68 | [A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer]. ( Abeler, V; Kaern, J; Kjørstad, KE; Nordal, R; Sandvei, R; Sundfør, K; Tropé, C; Vergote, I; Vossli, S, 1990) |
| " This study provided evidence that the combination of DP and amphotericin B (AmB) significantly potentiated the inhibitory effect of 5-fluorouracil (FU) or methotrexate (MTX) against a panel of transplantable tumors including sarcoma 180, cervical carcinoma U14, and Lewis lung carcinoma in mice." | 3.67 | Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B. ( Cao, SS; Zhen, YS, 1989) |
| "To select suitable chemotherapy for cervical cancer patients by ATP-tumor chemosensitivity assay." | 2.78 | [ATP-tumor chemosensitivity assay directed chemotherapy in patients with cervical cancer]. ( Jiang, Y; Yang, L; Yuan, Z; Zhang, Y; Zhao, Q, 2013) |
| "Patients with previously untreated cervical cancer, with Stage III/IVA disease, or Stage IB/II with high-risk factor (primary tumor diameter >/=50 mm or positive lymph node) were entered into this study." | 2.74 | Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma. ( Fuwa, N; Inokuchi, H; Kodaira, T; Nakahara, R; Nakamura, T; Nakanishi, T; Tachibana, H; Tomita, N, 2009) |
| "Twenty women with squamous cell cervical cancer were randomly assigned to receive ether standard whole pelvic radiotherapy with concurrent cisplatin and fluorouracil infusion every 4 weeks or the same radiotherapy with concurrent cisplatin every 1 week." | 2.74 | Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study. ( Penpattanagul, S; Porapakkhan, P; Sukhaboon, J, 2009) |
| "2004, 285 patients with stage IIB-IIIB cervical cancer treated in Maternal and Child Health Hospital of Jiangxi Province were randomly assigned to receive radiotherapy alone or concurrent chemoradiotherapy." | 2.73 | [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma]. ( Li, HP; Li, LY; Luo, B; Pan, M; Shu, KY; Zeng, SY, 2008) |
| "Celecoxib was prescribed at 400 mg twice daily beginning on day 1 for 1 year." | 2.73 | A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128. ( Avizonis, V; Dicker, AP; Eifel, PJ; Fromm, M; Gaffney, DK; Greven, K; Miller, B; Ryu, J; Winter, K, 2007) |
| "Celecoxib was prescribed at a dose of 400 mg twice daily for 1 year beginning on the first day of radiotherapy." | 2.73 | Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128. ( Avizonis, V; Dicker, AP; Eifel, PJ; Fromm, M; Gaffney, DK; Greven, K; Miller, B; Ryu, J; Small, W; Winter, K, 2007) |
"These specimens were evaluated for DNA aneuploidy (DI | 2.73 | Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial. ( Crook, W; Eifel, PJ; Gaffney, DK; Grigsby, PW; Krishan, A; Lucci, JA; Markoe, AM; Morris, M; Winter, K; Wolfson, AH, 2008) | |
| "Ten patients with advanced or recurrent cancer of the cervix with no prior chemotherapy were entered in a phase II trial from October 2000 to November 2001." | 2.71 | First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a phase II study. ( Behtash, N; Ghaemmaghami, F; Khanafshar, N; Modares, M; Moosavi, A; Toogeh, G; Yarandi, F, 2003) |
| "Four hundred three women with cervical cancer were randomly assigned to receive either EFRT or CTRT." | 2.71 | Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. ( Cooper, J; Eifel, PJ; Gershenson, D; Grigsby, PW; Levenback, C; Morris, M; Mutch, DG; Rotman, M; Winter, K, 2004) |
| "Japanese women with low-stage cervical cancer receiving radical hysterectomy and radiotherapy have a good 5-year survival rate." | 2.71 | Adjuvant oral 5-fluorouracil for cervical cancer: Japanese Gynecologic Oncology Group report. ( Hasegawa, K; Izumi, R; Kudo, R; Nakajima, H; Ohashi, K; Okuda, H; Origasa, H; Sugimori, H; Takahashi, T; Yamamoto, K, 2004) |
| "Stage IIIB cervical cancer patients with bilateral parametrial involvement have a poor prognosis with low survival rates." | 2.71 | Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study. ( Araujo, CM; Dantas, MA; Froimtchuk, M; Marchiori, E; Oliveira, JA; Souhami, L; Viegas, CM, 2004) |
| "We wanted to examine the tolerability and the toxicity of the chemoimmunotherapy in combination with radiotherapy in patients with stage III B cervical cancer." | 2.71 | [Chemoimmunoterapy in combination with radiotherapy for treatment of stage III B cervical cancer]. ( Ivanov, S, 2005) |
| "In a phase II IRB approved trial, capecitabine was given at a dosage of 2000 mg/m2/day orally in a divided dose daily for 14 days followed by a 7-day rest period." | 2.71 | Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. ( Atkinson, EN; Bodurka, DC; Brown, J; Jenkins, AD; Johnston, T; Levenback, C; Ramondetta, LM; Sun, C; Wolf, JK, 2005) |
| " Future research should explore combinations of FU with cisplatin, new radiosensitizers, and active drugs combined with RT to reduce the high rate of pelvic and distant treatment failure still seen in advanced cervix cancer." | 2.71 | Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. ( Bundy, BN; Calkins, A; Lanciano, R; Lucci, JA; Monk, BJ; Moore, DH; O'Connor, DM; Parham, G, 2005) |
| "The overall response rate in the 18 cervical cancer patients was 89% (78% complete, 11% partial)." | 2.69 | Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies. ( Fleming, G; Mundt, AJ; Quiet, C; Rotmensch, J; Waggoner, S, 1999) |
| "All patients had biopsy-proven invasive squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix." | 2.69 | Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. ( Bundy, BN; Clarke-Pearson, DL; Fowler, WC; Hannigan, EV; Liao, SY; Malfetano, JH; Sause, W; Whitney, CW, 1999) |
| "As a result, the number of cervical cancer patients who visit radiotherapy departments has decreased significantly." | 2.69 | [Radiotherapy for cervical cancer: a multi-institutional comparison]. ( Ito, H, 1999) |
| " The Kaplan-Meier overall and cancer specific survival analysis estimates that the chronic administration of antimetabolites did not improve the cumulative 5-year survival in the SCC group." | 2.68 | [Usefulness of adjuvant chemotherapy with antimetabolites for cervical invasive cancer]. ( Hirota, Y; Hongo, J; Iijima, Y; Inagaki, M; Koyama, M; Ozaki, M; Wada, K, 1995) |
| "Treatment with sizofiran and 5-fluorouracil in combination improved (P = 0." | 2.68 | Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival. ( Fujisaki, S; Fukuma, K; Katabuchi, H; Miyazaki, K; Mizutani, H; Okamura, H, 1995) |
| "Total 21 cases of cervical cancer were alloted randomly into 5'-DFUR group (daily dose 800 mg for 3 days) consisting of 11 patients and UFT group (daily dose 600 mg for 3 days) consisting of 10 patients, the unchanged substances (5'-DFUR in the 5'-DFUR group and tegafur concentrations in the UFT group) and 5-FU concentrations in serum and tissues were measured 6 hours after administration of the drugs." | 2.68 | [5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer]. ( Aida, I; Kasuga, Y; Ohwada, M; Sato, I; Suzuki, M; Tamura, T, 1995) |
| "Sixty women with advanced cervical cancer (30 patients with unfavorable Stage IIB and 30 patients with Stages III and IVA) were treated with CR comprising of a combination of external and intracavitary RT delivering between 7000 to 7500 cGy total to point A and 5890 to 6015 cGy to point B along with one cycle of 5-FU and mitomycin C and a second cycle of 5-FU and cis-platinum." | 2.68 | Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15. ( Caplan, R; Flam, M; John, M; Quivey, J; Rotman, M; Russell, A; Steinfeld, A, 1996) |
| "Sixty-three patients developed distant metastases or local relapse, 30 in the CT + RT group and 33 in the RT group." | 2.68 | Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. ( Bertelsen, K; Högberg, T; Koern, J; Onsrud, M; Simonsen, E; Sundfør, K; Tropé, CG; Westberg, R, 1996) |
| "Twenty-eight patients with recurrent squamous carcinoma of the cervix not amenable to cure by further surgery or radiation therapy were entered into a Phase II trial utilizing i." | 2.67 | 5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group. ( Blessing, JA; Look, KY; Malfetano, JH; Muss, HB; Partridge, EE, 1992) |
| "Most women with early cervical cancer (stages I to IIA) are cured with surgery or radiotherapy, or both." | 2.53 | Adjuvant platinum-based chemotherapy for early stage cervical cancer. ( Edelweiss, MI; Falcetta, FS; Medeiros, LR; Pohlmann, PR; Rosa, DD; Stein, AT, 2016) |
| "Patients were diagnosed with cervical cancer FIGO stage IIB to IVA with a histopathology of squamous cell carcinoma, adenosquamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma." | 2.50 | Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. ( Katanyoo, K; Laopaiboon, M; Lumbiganon, P; Manusirivithaya, S; Supawattanabodee, B; Tangjitgamol, S, 2014) |
| "Most women with early cervical cancer (stages I to IIA) are cured with surgery or radiotherapy, or both." | 2.48 | Adjuvant platinum-based chemotherapy for early stage cervical cancer. ( Edelweiss, MI; Medeiros, LR; Pohlmann, PR; Rosa, DD; Stein, AT, 2012) |
| "Atypical carcinoid tumors of the uterine cervix represent rare neuroendocrine tumors and are highly aggressive, showing early lymphatic invasion and hematogenous distant metastases." | 2.47 | Atypical metastatic carcinoid of the uterine cervix and review of the literature. ( Imamura, Y; Katayama, K; Kotsuji, F; Sato, K; Yamaguchi, A; Yoshida, Y, 2011) |
| "In response to repeated observations of cervical cancers in HIV-infected women, moderate and severe cervical dysplasia were designated as early symptomatic HIV infection (Category B) by the Centers for Disease Control and Prevention (CDC) in 1993, and invasive cervical cancer as an AIDS-defining condition (Category C)." | 2.43 | Cervical screening and management of cervical intraepithelial neoplasia in HIV-positive women. ( Bradbeer, C; Danso, D; Lyons, F, 2006) |
| "Among gynecologic cancers, ovarian cancer is treated with chemotherapy as a routine practice." | 2.41 | [Gynecologic cancer-evidenced based chemotherapy]. ( Ochiai, K, 2000) |
| " Adequate radiation dosing (both external beam and intracavitary) is essential." | 2.41 | Advanced cervical cancer. ( Gibbons, SK; Keys, HM, 2000) |
| "Locally advanced cervical cancer has a poor prognosis, poor survival rate, and high local failure rate." | 2.40 | [Clinical evaluation of chemoradiotherapy for advanced cervical cancer]. ( Kaneyasu, Y; Okawa, MK; Okawa, T, 1997) |
| "The implantation of cervical cancer in an episiotomy scar is very rare." | 2.38 | Squamous cell carcinoma of the cervix implanting in the episiotomy site. ( Issa, PY; Khalil, AM; Khatib, RA; Mufarrij, AA; Tawil, AN, 1993) |
| "Solid lipid nanoparticles (SLNs) are used extensively to achieve site-specific drug delivery with improved bioavailability and reduced toxicity." | 1.91 | In Vitro Prototyping of a Nano-Organogel for Thermo-Sonic Intra-Cervical Delivery of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles for Cervical Cancer. ( Adeyemi, SA; Az-Zamakhshariy, Z; Choonara, YE, 2023) |
| "However, morphine did not affect cervical cancer cell survival." | 1.72 | Morphine stimulates cervical cancer cells and alleviates cytotoxicity of chemotherapeutic drugs via opioid receptor-dependent and -independent mechanisms. ( Jin, S; Tian, S; Wang, Z; Yu, Z, 2022) |
| "Cervical cancer is one of the most diagnosed malignancies among females." | 1.62 | Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis. ( Liu, G; Liu, Y; Ma, D; Shao, X; Zheng, X, 2021) |
| "The dosage of cisplatin is adjusted according to creatinine clearance (Ccr) estimated by the Cockcroft-Gault formula, which is commonly used as a marker for renal function." | 1.51 | [Effects of Renal Function Evaluation with or without Serum Creatinine Adjustment on Cisplatin/Fluorouracil Therapy for Cervical Cancer]. ( Ishizawa, A; Ito, A; Miyazaki, M; Nagai, T; Sagara, A; Senzaki, K; Takagi, M; Yamada, K, 2019) |
| "Cervical cancer is a major cause of cancer-related death in women world-wide." | 1.51 | Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation. ( Das, S; Kundu, CN; Narayan, S; Nayak, A; Nayak, D; Sethy, C, 2019) |
| "Curcumin is a natural non-toxic phenol which is isolated from Curcumin longa L." | 1.51 | Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. ( Amiri Moghadam, S; ArefNezhad, R; Avan, A; Banikazemi, Z; Ghasemi, F; Khanbabaei, H; Mirzaei, H; Pourhanifeh, MH; Sahebkar, A; Shafiee, M; Shamshirian, A, 2019) |
| "Our previous data illustrated that cervical cancer patients whose specimens overexpressed microR-492 (miR-492) were highly sensitive to concurrent chemoradiation." | 1.48 | Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro. ( Liu, M; Liu, Q; Wang, Z; Xu, N; Zhu, H, 2018) |
| "Of 216 stage IIIB cervical cancer patients, 114 of them had no LTI and 72 had LTI." | 1.46 | Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion. ( Katanyoo, K, 2017) |
| "5-fluorouracil was associated with a 74% success rate as the initial treatment modality for high-grade vaginal dysplasia." | 1.46 | Topical 5-Fluorouracil for Women With High-Grade Vaginal Intraepithelial Neoplasia. ( Feldman, S; Fiascone, S; Vitonis, AF, 2017) |
| "A pathologic cervical residual tumor was observed in 16 patients (35." | 1.43 | [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy]. ( Ballester, M; Daraï, E; Huguet, F; Lauratet, B; Lefranc, JP; Monnier, L; Touboul, E, 2016) |
| " Most adverse events were mild (grade 1-2) (Common Terminology Criteria for Adverse Events, version 3." | 1.42 | Feasibility and Safety of Negative-Balance Isolated Pelvic Perfusion in Patients with Pretreated Recurrent or Persistent Uterine Cervical Cancer. ( Kumita, S; Mine, T; Murata, S; Onozawa, S; Sakamoto, A; Sugihara, F; Ueda, T; Yamaguchi, H; Yasui, D, 2015) |
| "The main methods of treatment for cervical cancer are surgery, radiotherapy or their combination." | 1.42 | [Induction chemotherapy for locally advanced cervical cancer]. ( Kuznetsov, VV; Morkhov, KY; Nechushkina, VM, 2015) |
| "Different treatments for cervical cancer, including radiotherapy (HR 1." | 1.42 | Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study. ( Chao, Y; Chen, TJ; Hu, YW; Hung, YP; Huon, LK; Liu, CJ; Teng, CJ; Yang, MH; Yeh, CM, 2015) |
| " Our chemoradiotherapy protocol was as follows: (i) alternating chemoradiotherapy with 5-fluorouracil and nedaplatin; (ii) whole pelvic radiotherapy with the dynamic conformal technique combined with intracavitary brachytherapy; (iii) prophylactic irradiation to the para-aortic region for International Federation of Gynecology and Obstetrics III/IVA or positive pelvic node and full-dose radiotherapy for positive para-aortic node." | 1.40 | Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer. ( Fuwa, N; Hirata, K; Ito, J; Kodaira, T; Nakanishi, T; Ohshima, Y; Tachibana, H; Tomita, N, 2014) |
| "For the 83 patients with HPV 16-cancer of the cervix (cervical cancer) I-III stages it was performed a comparative analysis of primary tumor response to therapy, the clinical outcome of the disease for 3-5 years after radical treatment and an evaluation of the possible contribution in these rates of the physical status of the virus." | 1.39 | [The significance of physical status of human papillomavirus type 16 for predicting the effectiveness of invasive cervical cancer treatment]. ( Beziaeva, GP; Kiseleva, VI; Krikunova, LI; Liubina, LV; Mkrtchian, LS; Panarina, LV; Saenko, AS; Zamulaeva, IA, 2013) |
| "Between 1990 and 2010, 110 cervical cancer patients with 2 or more intermediate risk factors (deep stromal invasion, lymphovascular space invasion, and large tumor size) underwent adjuvant RT (n=56) or CCRT (n=54) following radical surgery." | 1.38 | 20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy. ( Ha, SW; Kang, SB; Kim, HJ; Kim, JH; Kim, JW; Park, NH; Song, C; Song, S; Song, YS; Wu, HG, 2012) |
| "To study the efficacy of low-dose-rate californium-252 ((252)Cf) neutron intracavitary afterloading radiotherapy (RT) combined with external pelvic RT for treatment of cervical cancer." | 1.38 | Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer. ( Lin, S; Liu, JR; Pan, SD; Xu, HD; Yue, JH; Zhang, M, 2012) |
| "The prognosis of stage IVB cervical cancer is generally poor." | 1.38 | Outcomes and toxicities for the treatment of stage IVB cervical cancer. ( Hwang, JH; Kang, S; Kim, JY; Lim, MC; Park, SY; Seo, SS, 2012) |
| "ACA in locally advanced cervical cancer had poorer response rate from treatment and also used longer time to achieve CR than SCC." | 1.38 | Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. ( Katanyoo, K; Manusirivithaya, S; Sanguanrungsirikul, S, 2012) |
| "To evaluate the outcome of stage IVA cervical cancer treated with radiation and concurrent cisplatin-based chemotherapy." | 1.37 | Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study. ( Ali, S; Lanciano, R; Rose, PG; Stehman, FB; Whitney, CW, 2011) |
| "Cervical cancer is one of the most common cancers diagnosed in women worldwide." | 1.37 | Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. ( Chen, CC; Ho, SC; Jan, JS; Lin, JC; Wang, L, 2011) |
| "Records of 632 patients with cervical cancer stage II - IVa proved by pathology in Lanzhou Command General Hospital from January 1st, 1999 to August 31st, 2009 were retrospective analysed." | 1.36 | [Clinical value of the comprehensive treatment in intermediate and advanced cervical cancer with uterine arterial interventional chemoembolization and radiotherapy]. ( Chen, XH; Li, S; Liu, ML; Tian, ZZ; Yue, YJ; Zhao, R; Zhu, XH, 2010) |
| "We investigated the role of squamous cell carcinoma (SCC) at presentation (pre-SCC) and after treatment (post-SCC) as predictor of pathological response and outcome in locally advanced cervical cancer (LACC) patients undergoing preoperative chemoradiation." | 1.35 | Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome. ( Carone, V; Deodato, F; Digesù, C; Ferrandina, G; Forni, F; Legge, F; Macchia, G; Morganti, AG; Scambia, G, 2008) |
| "SS in cervical cancer is a feasible and safe pretreatment procedure, and when associated with CT, it improves OS and DFS." | 1.35 | Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy. ( Clagnan, WS; de Andrade, JM; Dos Reis, FJ; Garieri, AP; Marana, HR; Tiezzi, DG; Zola, FE, 2009) |
| "The prognosis of recurrent metastatic cervical cancer is extremely poor." | 1.34 | Unexpected long-term survival without evidence of disease after salvage chemotherapy for recurrent metastatic cervical cancer: a case series. ( Abu-Rustum, NR; Aghajanian, C; Bowes, RJ; Jhamb, N; Khoury-Collado, F, 2007) |
| "The sensitivity of fresh human cervical cancer cells from 32 patients to 9 cytotoxic drugs was tested using in vitro MTT assay." | 1.34 | [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer]. ( Feng, YL; Li, JD; Li, MD; Liu, JH; Shi, HL; Xiao, Y, 2007) |
| "We evaluated 81 patients with uterine cervical cancer who underwent three serial MR examinations, i." | 1.34 | The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. ( Ahn, YC; Bae, DS; Han, Y; Huh, SJ; Kim, BG; Lee, JH; Lee, JW; Lim, DH; Nam, H; Park, HC; Park, W, 2007) |
| "101 patients with cervical cancer FIGO IB1-IVB underwent chemoradiation after transperitoneal laparoscopic staging." | 1.34 | Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging. ( Bischoff, A; Budach, V; Füller, J; Köhler, C; Marnitz, S; Roth, C; Schneider, A; Wendt, T, 2007) |
| " The adverse effect included grade 3 or grade 4 leukopenia in 12." | 1.34 | [Efficiency and side effects of concurrent radiotherapy and chemotherapy for advanced cervical cancers]. ( Bai, P; Li, XG; Ma, SK; Wu, LY; Zhang, R; Zhang, WH, 2007) |
| "Totally 197 patients with primary cervical cancer in our hospital from 2000 to 2006 were studied." | 1.34 | [Retrospective study of chemoradiotherapy based on cisplatin compared with radiotherapy alone for cervical cancer]. ( Han, C; Kong, WM, 2007) |
| "Most patients (95%) had histology of squamous cell carcinoma." | 1.33 | Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan. ( Inoue, T; Kawaguchi, A; Kodaira, T; Maebayashi, K; Mitsuhashi, N; Nakamura, K; Ogawa, K; Shinoda, A; Teshima, T; Toita, T; Uno, T, 2005) |
| "Most cervical cancer patients with pelvic recurrent or persistent disease are not candidates for exenteration, therefore, they only receive palliative chemotherapy." | 1.33 | Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer. ( Brom, R; Candelaria, M; Cantu, D; Cetina, L; Chanona, J; de la Garza, J; Dolores, R; Duenas-Gonzalez, A; Gonzalez, A; Lopez-Graniel, C; Uribe, J, 2005) |
| "Endpoints were recurrence and distant metastasis rates, overall survival (OS) and disease-free survival (DFS) at 5 and 10 years." | 1.33 | Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. ( Buttarelli, M; Goncalves, A; Gonzague-Casabianca, L; Houvenaeghel, G; Lelievre, L; Moutardier, V; Resbeut, M, 2006) |
| " To optimize radiotherapy, dosage was reduced by 10% or daily single target dose of intracavitary and distant irradiation split per 24 hrs, indications for preoperative radiotherapy variants were extended, and local dosage escalation in areas of lymphocyst or hematoma renounced." | 1.33 | [Improvement of postoperative radiotherapy in the complex treatment of stage II-III cervical cancer]. ( Kreĭnina, IuM; Povarova, EV; Shevchenko, LN; Shipilova, AN; Titova, VA, 2006) |
| "The radiosensitive human cervical squamous cell carcinoma cell line ME180 was examined to investigate the effects of 5FU on radiosensitivity and the effects of irradiation on 5FU-sensitivity." | 1.33 | Effective chemoradiotherapy protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitro. ( Tanaka, T; Umesaki, N; Yukawa, K, 2006) |
| "The prognosis of locally advanced cervix cancers is poor with metastatic and local recurrence risks." | 1.31 | [Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]]. ( Beuzeboc, P; Chauveinc, L; Clough, KB; Cosset, JM; de la Rochefordière, A; Guyonnet, M; Mouret-Fourme, E; Nguyen, D, 2002) |
| "In the patients with squamous cell carcinoma, 100 mg/m2 of cisplatin was infused intravenously, followed immediately by five consecutive daily administrations of 5-fluorouracil, 1,000 mg/m2/day, each infused intravenously over 24 hr." | 1.31 | Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors. ( Kim, GE; Kim, SN; Kim, SW; Park, TK; Suh, CO, 2000) |
| "Various approaches have been made to increase the cytotoxicity of cis-platinum (CDDP) and 5-fluorouracil (5FUra), and to reduce their adverse effects." | 1.31 | Indomethacin increases the cytotoxicity of cis-platinum and 5-fluorouracil in the human uterine cervical cancer cell lines SKG-2 and HKUS by increasing the intracellular uptake of the agents. ( Minoura, S; Ogino, M, 2001) |
| " The dosage of cisplatin was 20 mg/m2/d on every day and 5-FU was given as a 120-h infusion with 600 mg/m2/d." | 1.31 | [Adjuvant simultaneous radiochemotherapy after operated uterine cervix carcinoma in high risk situation. Results of a pilot study]. ( Dunst, J; Hänsgen, G; Kuhnt, T; Pigorsch, S; Strauss, H, 2002) |
| "Fluorouracil (5-FU) was repeatedly injected into the pelvic retroperitoneal space of 43 patients and the abdominal cavity of 11 patients." | 1.30 | [The contrast between chemotherapy via pelvic retroperitoneal cannulation and intraperitoneal chemotherapy in gynecological malignancies cancers with lymph node metastases]. ( Cao, Z; Peng, Z; Zhang, D, 1999) |
| "Chemotherapy for cervical cancer patients with recurrent and/or advanced disease has been complicated by excessive toxicity and short duration of responses, leading to little or no improvement in survival." | 1.29 | Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol. ( Chambers, JT; Chambers, SK; Kohorn, EI; Lamb, L; Schwartz, PE, 1994) |
| "In patients with locally advanced cervical cancer, most of the treatment failures occur within the pelvis." | 1.29 | Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. ( Boubli, L; Cowen, D; Delpero, JR; Gamerre, M; Gouvernet, J; Houvenaeghel, G; Noirclerc, M; Perez, T; Resbeut, M; Viens, P, 1994) |
| "Twenty four patients with advanced cancer of cervix were submitted to sequential chemotherapy 5FU and MTX." | 1.28 | Sequential MTX-5 FU chemotherapy in pallination of advanced cancer cervix. ( Mathur, RK; Mathur, V; Sharma, K; Tripathi, N, 1992) |
| "Ten patients with squamous cell carcinoma of the cervix metastatic to periaortic lymph nodes were treated with external-beam radiation therapy and synchronous infusion of intravenous 5-fluorouracil (5-FU) chemotherapy at doses of 350 mg/m2/day." | 1.28 | Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervix. ( Drescher, CW; Hopkins, MP; Perez-Tamayo, C; Reid, GC; Roberts, JA; Schoeppel, SL; Terada, K, 1992) |
| "Therapeutic results in advanced cervical cancer have not been showing any progress for more than 30 years." | 1.28 | [Systemic therapy in recurrent and primary advanced cervix cancer]. ( Bastert, G; Junkermann, H; Kaufmann, M; Schmid, H; Schönig, T; von Fournier, D, 1991) |
| "Radiation myelitis is a rare but serious complication of radiation therapy." | 1.28 | Radiation myelitis: a complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of the uterine cervix. ( Berman, ML; Bloss, JD; DiSaia, PJ; Hyden, EC; Manetta, A; Mannel, RS; Walker, JL, 1991) |
| "In uterine cervical cancer, each group of 9 cases administered single dose of 400 mg of 5'-DFUR and 7 cases administered 400 mg of 5'-DFUR 3 times a day continuously for 7 days was investigated." | 1.28 | [Investigation of 5-fluorouracil (5-FU) levels and pyrimidine nucleoside phosphorylase activities in the tissues from patients with uterine cervical and ovarian cancers after oral administration of 5'-DFUR]. ( Hasegawa, K; Ikeda, M; Kinugasa, M; Kobashi, Y; Noda, K; Odagiri, H; Ohiwa, T; Sekiba, K; Takeuchi, K; Watanabe, Y, 1991) |
| "Nephrotoxicity is the major side effect of cisplatinum (CDDP) and it is often the dose limiting factor." | 1.28 | [Effects of urinastatin against nephrotoxicity of cisplatinum]. ( Arakawa, A; Asai, H; Kato, N; Suzumori, K; Yagami, Y; Yasui, Y, 1990) |
| " The following pharmacokinetic results were obtained in comparison with single administration." | 1.27 | [Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (II) Pharmacokinetics in continuous administration at a daily dose of 1 gram]. ( Chin, N; Endoh, S; Fukui, H; Hasegawa, T; Hayashi, Y; Ishii, Y; Kohno, I; Nakagiri, Y; Okazaki, H; Rin, K, 1984) |
| " HCFU might be effective against gynecologic cancers when used in maintenance therapy at a lower dosage (300--400 mg) than previously estimated." | 1.27 | Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue. ( Matsui, Y; Okudaira, Y; Sawada, M, 1983) |
| " The drug sensitivity of the cultured cancer cells was investigated with a colony forming assay, and a dose-response curve was obtained for the time-dependent anticancer drug." | 1.27 | [Studies on oral-adjuvant chemotherapy of uterine cervical cancer after surgical treatment]. ( Maeda, T, 1986) |
| "Eleven patients who had advanced cancer of the cervix were treated with combination chemotherapy containing Cisplatin as a primary treatment." | 1.27 | [Value of initial chemotherapy in the treatment of advanced cancers of the uterine cervix]. ( Barrier, J; Bercau, G; Ciraru-Vigneron, N; Espie, M; Marty, M; Mignot, L; Muray, JM; Payraudeau-Daoud, P, 1987) |
| "One-hundred-fifteen patients with cervical cancer were treated by placing bleomycin, carbazilquinone (Carboquone), and 5-fluorouracil suppositories in contact with cancer lesions located in the vaginal portion of the uterus or by inserting them into the cervical canal, twice a week, one to 14 times." | 1.26 | Local therapy of carcinoma of the uterine cervix: part I. ( Fujiyama, N; Iwata, M; Kikyo, T; Machida, Y; Masuda, H; Nagai, K; Shiojima, Y; Suda, T; Sumiyoshi, Y, 1981) |
| " Daily dosage of FT-207 was either 600 or 800 mg and the drug was administered orally." | 1.26 | [FT-207 maintenance therapy of malignant gynecologic cancer]. ( Jimi, S; Kato, Y; Kawakami, M; Kidera, Y; Matsuyama, T; Morita, T; Nishimura, A; Shigyo, R; Sugimori, H; Tanaka, M; Toyota, Y; Tsukamoto, N; Watanabe, E; Yamashita, H, 1982) |
| "Thirty-one patients with advanced stage squamous cell carcinoma of the cervix were treated with the four-drug combination fluorouracil, doxorubicin, cyclophosphamide, and vincristine." | 1.26 | Four-drug combination chemotherapy for advanced cervical carcinoma. ( Aroney, RS; Chan, WK; Fox, RM; Levi, JA; Tattersall, MH; Woods, RL, 1982) |
| "Eight patients with squamous cell carcinoma in situ of the vagina were treated with monthly 5 day courses of 20% 5-fluorouracil cream applied to the vagina." | 1.26 | Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 percent 5-fluorouracil cream. ( Barlow, JJ; Gamarra, M; Piver, MS; Sandecki, A; Tsukada, Y, 1979) |
| " A combination of chemical substances and the dosage of single administration were as follows: thio-TEPA--100--150 mg + methotrexate 75--100 mg; thio-TEPA--100--150 mg + 5-fluoruracil--1000 mg; cyclophosphane--2000 mg + methotrexate--75--100 mg; cyclophosphane--1600 mg + methotrexate--75--100 mg + 5-fluoruracil--750 mg." | 1.26 | [Endolymphatic chemotherapy of cervix neoplasms]. ( Birbraer, VM; Bordiushkov, IuN; Il'inskaia, EG; Pankov, AK; Sidorenko, IuS, 1976) |
| "All 14 patients with breast carcinoma underwent remission and in 6 this was complete." | 1.25 | Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime. ( Hanham, IW; Newton, KA; Westbury, G, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 115 (26.74) | 18.7374 |
| 1990's | 103 (23.95) | 18.2507 |
| 2000's | 117 (27.21) | 29.6817 |
| 2010's | 88 (20.47) | 24.3611 |
| 2020's | 7 (1.63) | 2.80 |
| Authors | Studies |
|---|---|
| Cristalli, G | 1 |
| Franchetti, P | 1 |
| Grifantini, M | 1 |
| Vittori, S | 1 |
| Bordoni, T | 1 |
| Geroni, C | 1 |
| Yu, M | 1 |
| Yang, H | 1 |
| Wu, K | 1 |
| Ji, Y | 1 |
| Ju, L | 1 |
| Lu, X | 1 |
| Yu, Z | 1 |
| Jin, S | 1 |
| Tian, S | 1 |
| Wang, Z | 2 |
| Mao, J | 1 |
| Yang, W | 1 |
| Guo, H | 1 |
| Dong, R | 1 |
| Ren, L | 1 |
| Li, S | 2 |
| Adeyemi, SA | 1 |
| Az-Zamakhshariy, Z | 1 |
| Choonara, YE | 1 |
| Desravines, N | 1 |
| Hsu, CH | 1 |
| Mohnot, S | 1 |
| Sahasrabuddhe, V | 1 |
| House, M | 1 |
| Sauter, E | 1 |
| O'Connor, S | 1 |
| Bauman, JE | 1 |
| Chow, HS | 1 |
| Rahangdale, L | 2 |
| Khumkhrong, P | 1 |
| Piboonprai, K | 1 |
| Chaichompoo, W | 1 |
| Pimtong, W | 1 |
| Khongkow, M | 1 |
| Namdee, K | 1 |
| Jantimaporn, A | 1 |
| Japrung, D | 1 |
| Asawapirom, U | 1 |
| Suksamrarn, A | 1 |
| Iempridee, T | 1 |
| Takagi, M | 1 |
| Sagara, A | 1 |
| Ishizawa, A | 1 |
| Ito, A | 1 |
| Miyazaki, M | 1 |
| Senzaki, K | 1 |
| Nagai, T | 2 |
| Yamada, K | 1 |
| Yuan, Y | 1 |
| You, J | 1 |
| Li, X | 1 |
| Wang, W | 1 |
| Shao, X | 1 |
| Zheng, X | 1 |
| Ma, D | 1 |
| Liu, Y | 3 |
| Liu, G | 1 |
| Fu, H | 1 |
| Zuo, L | 1 |
| Yang, T | 1 |
| Aimaiti, M | 1 |
| Su, D | 1 |
| Miao, W | 1 |
| Zhou, B | 1 |
| Maimaitiyiming, D | 1 |
| Yusup, A | 1 |
| Upur, H | 1 |
| Aikemu, A | 1 |
| Miyauchi, R | 1 |
| Itoh, Y | 2 |
| Kawamura, M | 1 |
| Hirakawa, A | 1 |
| Shibata, K | 2 |
| Kajiyama, H | 2 |
| Nakahara, R | 2 |
| Kubota, S | 1 |
| Ito, J | 3 |
| Okada, T | 1 |
| Kikkawa, F | 2 |
| Naganawa, S | 1 |
| Katanyoo, K | 3 |
| Fiascone, S | 1 |
| Vitonis, AF | 1 |
| Feldman, S | 1 |
| Ryu, H | 1 |
| Song, IC | 1 |
| Choi, YS | 2 |
| Yun, HJ | 1 |
| Jo, DY | 1 |
| Kim, JM | 1 |
| Ko, YB | 1 |
| Lee, HJ | 1 |
| Xi, C | 1 |
| Wang, L | 2 |
| Yu, J | 1 |
| Ye, H | 1 |
| Cao, L | 1 |
| Gong, Z | 1 |
| Fu, T | 1 |
| Guang, HJ | 1 |
| Gao, XZ | 1 |
| Liu, M | 1 |
| Liu, Q | 1 |
| Zhu, H | 2 |
| Xu, N | 1 |
| Nayak, A | 1 |
| Das, S | 1 |
| Nayak, D | 1 |
| Sethy, C | 1 |
| Narayan, S | 1 |
| Kundu, CN | 1 |
| Aydinlik, S | 1 |
| Dere, E | 1 |
| Ulukaya, E | 1 |
| Ghasemi, F | 1 |
| Shafiee, M | 1 |
| Banikazemi, Z | 1 |
| Pourhanifeh, MH | 1 |
| Khanbabaei, H | 1 |
| Shamshirian, A | 1 |
| Amiri Moghadam, S | 1 |
| ArefNezhad, R | 1 |
| Sahebkar, A | 1 |
| Avan, A | 1 |
| Mirzaei, H | 1 |
| Lee, DW | 2 |
| Lee, KH | 3 |
| Lee, JW | 6 |
| Park, ST | 1 |
| Park, JS | 3 |
| Lee, HN | 2 |
| Kim, HS | 2 |
| Yi, BR | 1 |
| Hwang, KA | 1 |
| Kim, SU | 1 |
| Choi, KC | 1 |
| Donnelly, ED | 1 |
| Refaat, T | 1 |
| Gentile, M | 1 |
| Herskovic, A | 1 |
| Boyle, J | 1 |
| Helenowski, I | 1 |
| Rademaker, A | 1 |
| Lurain, J | 1 |
| Schink, J | 1 |
| Singh, D | 1 |
| Strauss, JB | 1 |
| Small, W | 2 |
| Oh, D | 1 |
| Lee, JE | 1 |
| Huh, SJ | 5 |
| Park, W | 3 |
| Nam, H | 2 |
| Choi, JY | 1 |
| Kim, BT | 1 |
| Lee, YY | 3 |
| Yoon, A | 1 |
| Park, JY | 1 |
| Choi, CH | 4 |
| Kim, TJ | 4 |
| Kim, BG | 5 |
| Bae, DS | 5 |
| Roberts, OA | 1 |
| Owonikoko, KM | 1 |
| Abdus-Salam, AA | 1 |
| Ogun, O | 1 |
| Hequet, D | 1 |
| Marchand, E | 1 |
| Place, V | 1 |
| Fourchotte, V | 1 |
| De La Rochefordière, A | 2 |
| Dridi, S | 1 |
| Coutant, C | 1 |
| Lecuru, F | 2 |
| Bats, AS | 1 |
| Koskas, M | 1 |
| Bretel, JJ | 1 |
| Bricou, A | 1 |
| Delpech, Y | 1 |
| Barranger, E | 1 |
| Likhacheva, A | 1 |
| Jhingran, A | 2 |
| Bodurka, DC | 3 |
| Sun, C | 2 |
| Sam, M | 1 |
| Eifel, PJ | 12 |
| Lippmann, QK | 1 |
| Garcia, K | 1 |
| Budwit, D | 1 |
| Smith, JS | 1 |
| van Le, L | 1 |
| Zhang, Y | 1 |
| Zhao, Q | 1 |
| Jiang, Y | 1 |
| Yuan, Z | 1 |
| Yang, L | 1 |
| Torii, Y | 1 |
| Kato, R | 2 |
| Minami, Y | 1 |
| Hasegawa, K | 6 |
| Fujii, T | 1 |
| Udagawa, Y | 2 |
| Li, XF | 1 |
| Li, YH | 1 |
| Gao, YN | 1 |
| Li, CL | 1 |
| Yue, HZ | 1 |
| Xu, G | 1 |
| Li, DM | 1 |
| Su, X | 1 |
| Ferrandina, G | 12 |
| Ercoli, A | 1 |
| Fagotti, A | 4 |
| Fanfani, F | 3 |
| Gallotta, V | 2 |
| Margariti, AP | 2 |
| Salerno, MG | 2 |
| Chiantera, V | 1 |
| Legge, F | 4 |
| Macchia, G | 8 |
| Morganti, AG | 7 |
| Valentini, V | 6 |
| Scambia, G | 13 |
| Kiseleva, VI | 1 |
| Krikunova, LI | 1 |
| Mkrtchian, LS | 1 |
| Liubina, LV | 1 |
| Beziaeva, GP | 1 |
| Panarina, LV | 1 |
| Saenko, AS | 1 |
| Zamulaeva, IA | 1 |
| Hirata, K | 1 |
| Kodaira, T | 4 |
| Tomita, N | 2 |
| Ohshima, Y | 1 |
| Tachibana, H | 3 |
| Nakanishi, T | 2 |
| Fuwa, N | 3 |
| Carmona, R | 1 |
| Pritz, J | 1 |
| Bydder, M | 2 |
| Gulaya, S | 1 |
| Williamson, CW | 1 |
| Welch, CS | 1 |
| Vaida, F | 1 |
| Bydder, G | 1 |
| Mell, LK | 3 |
| Bazaeva, IIa | 1 |
| Gorbunova, VA | 1 |
| Kravets, OA | 1 |
| Khokhlova, SV | 1 |
| Limareva, SV | 1 |
| Panov, VO | 1 |
| Strel'tsova, ON | 1 |
| Tarachkova, EV | 1 |
| Guseĭnov, KD | 1 |
| Maksimov, SIa | 2 |
| Urmancheeva, AF | 1 |
| Baranov, SB | 1 |
| Berlev, IV | 1 |
| Mikaia, NA | 1 |
| Rose, PG | 6 |
| Java, JJ | 1 |
| Whitney, CW | 3 |
| Stehman, FB | 4 |
| Lanciano, R | 3 |
| Thomas, GM | 4 |
| Tangjitgamol, S | 1 |
| Laopaiboon, M | 1 |
| Lumbiganon, P | 1 |
| Manusirivithaya, S | 2 |
| Supawattanabodee, B | 1 |
| Damnjanovic, I | 1 |
| Kocic, G | 1 |
| Najman, S | 1 |
| Stojanovic, S | 1 |
| Stojanovic, D | 1 |
| Veljkovic, A | 1 |
| Conic, I | 1 |
| Langerholc, T | 1 |
| Pesic, S | 1 |
| Gambacorta, A | 1 |
| Smaniotto, D | 6 |
| Tagliaferri, L | 1 |
| Foti, E | 1 |
| Autorino, R | 1 |
| Yan, CM | 1 |
| Zhao, YL | 1 |
| Cai, HY | 1 |
| Miao, GY | 1 |
| Ma, W | 1 |
| Murata, S | 1 |
| Onozawa, S | 1 |
| Sugihara, F | 1 |
| Sakamoto, A | 1 |
| Ueda, T | 1 |
| Yamaguchi, H | 1 |
| Yasui, D | 1 |
| Mine, T | 1 |
| Kumita, S | 1 |
| Xie, Q | 1 |
| Liang, J | 1 |
| Rao, Q | 1 |
| Xie, X | 1 |
| Li, R | 1 |
| Zhou, H | 1 |
| Han, J | 1 |
| Yao, T | 1 |
| Lin, Z | 1 |
| Sonoda, K | 1 |
| Yahata, H | 1 |
| Ichinoe, A | 1 |
| Okugawa, K | 1 |
| Kaneki, E | 1 |
| Kawano, Y | 1 |
| Kenjo, H | 1 |
| Ohgami, T | 1 |
| Yagi, H | 1 |
| Ohga, S | 1 |
| Asai, K | 1 |
| Nakamura, K | 2 |
| Honda, H | 2 |
| Kato, K | 1 |
| Morkhov, KY | 1 |
| Nechushkina, VM | 1 |
| Kuznetsov, VV | 1 |
| Takekuma, M | 1 |
| Kasamatsu, Y | 1 |
| Kado, N | 1 |
| Kuji, S | 1 |
| Tanaka, A | 1 |
| Takahashi, N | 1 |
| Abe, M | 1 |
| Hirashima, Y | 1 |
| Borycka-Kiciak, K | 1 |
| Białas, A | 1 |
| Wejman, J | 1 |
| Uchman-Musielak, M | 1 |
| Tarnowski, W | 1 |
| Teng, CJ | 1 |
| Huon, LK | 1 |
| Hu, YW | 1 |
| Yeh, CM | 1 |
| Chao, Y | 1 |
| Yang, MH | 1 |
| Chen, TJ | 1 |
| Hung, YP | 1 |
| Liu, CJ | 1 |
| Monnier, L | 1 |
| Touboul, E | 2 |
| Daraï, E | 1 |
| Lefranc, JP | 2 |
| Lauratet, B | 1 |
| Ballester, M | 1 |
| Huguet, F | 1 |
| Boupaijit, K | 1 |
| Suprasert, P | 1 |
| Vishnoi, K | 1 |
| Mahata, S | 1 |
| Tyagi, A | 1 |
| Pandey, A | 1 |
| Verma, G | 1 |
| Jadli, M | 1 |
| Singh, T | 1 |
| Singh, SM | 1 |
| Bharti, AC | 1 |
| He, B | 1 |
| Chai, Y | 1 |
| Wang, T | 1 |
| Zhou, Z | 1 |
| Liu, Z | 2 |
| Falcetta, FS | 1 |
| Medeiros, LR | 2 |
| Edelweiss, MI | 2 |
| Pohlmann, PR | 2 |
| Stein, AT | 2 |
| Rosa, DD | 2 |
| Zhang, F | 1 |
| Zhang, JG | 1 |
| Qu, J | 1 |
| Zhang, Q | 1 |
| Prasad, C | 1 |
| Wei, ZJ | 1 |
| Nakamura, T | 1 |
| Inokuchi, H | 1 |
| Cellini, N | 7 |
| Luzi, S | 1 |
| Balducci, M | 1 |
| Corvari, B | 2 |
| Margariti, PA | 4 |
| D'Agostino, G | 1 |
| Deodato, F | 3 |
| Forni, F | 1 |
| Digesù, C | 1 |
| Carone, V | 2 |
| Chen, H | 1 |
| Liang, C | 1 |
| Zhang, L | 1 |
| Huang, S | 1 |
| Wu, X | 1 |
| Tan, YT | 1 |
| Zhang, X | 1 |
| Lin, ZQ | 1 |
| Chen, Q | 1 |
| Wang, LJ | 1 |
| Zhang, BZ | 1 |
| Zeng, SY | 1 |
| Li, LY | 1 |
| Shu, KY | 1 |
| Pan, M | 1 |
| Li, HP | 1 |
| Luo, B | 1 |
| Kim, K | 3 |
| Kang, SB | 4 |
| Chung, HH | 3 |
| Kim, JW | 3 |
| Park, NH | 4 |
| Song, YS | 4 |
| Cao, DY | 1 |
| Yang, JX | 2 |
| Shen, K | 2 |
| Xiang, Y | 2 |
| Pan, LY | 1 |
| Lang, JH | 1 |
| Wu, M | 2 |
| Huang, HF | 2 |
| Li, H | 1 |
| Gou, HY | 1 |
| Han, JS | 1 |
| Li, SM | 1 |
| Yang, R | 1 |
| Qiao, J | 1 |
| Kim, YS | 3 |
| Kim, JH | 7 |
| Ahn, SD | 1 |
| Lee, SW | 1 |
| Shin, SS | 2 |
| Nam, JH | 2 |
| Kim, YT | 2 |
| Kim, YM | 2 |
| Choi, EK | 2 |
| Kim, DH | 1 |
| Wang-Chesebro, A | 1 |
| Weinberg, V | 1 |
| Pouliot, J | 1 |
| Chen, LM | 1 |
| Speight, J | 1 |
| Littell, R | 1 |
| Hsu, IC | 1 |
| Chung, WH | 1 |
| Sung, BH | 1 |
| Kim, SS | 1 |
| Rhim, H | 1 |
| Kuh, HJ | 1 |
| Lim, MC | 2 |
| Kim, JY | 5 |
| Yoo, CW | 1 |
| Park, SY | 2 |
| Marana, HR | 1 |
| de Andrade, JM | 1 |
| Dos Reis, FJ | 1 |
| Tiezzi, DG | 1 |
| Zola, FE | 1 |
| Clagnan, WS | 1 |
| Garieri, AP | 1 |
| Domingo, E | 1 |
| Lorvidhaya, V | 5 |
| de Los Reyes, R | 1 |
| Syortin, T | 1 |
| Kamnerdsupaphon, P | 2 |
| Lertbutsayanukul, C | 1 |
| Vito-Cruz, E | 1 |
| Tharavichitkul, E | 2 |
| Jin, K | 1 |
| Yoshihara, M | 1 |
| Cupino, N | 1 |
| Lertsanguansinchai, P | 3 |
| Sukhaboon, J | 1 |
| Porapakkhan, P | 1 |
| Penpattanagul, S | 1 |
| Maduro, JH | 1 |
| Noordhuis, MG | 1 |
| ten Hoor, KA | 1 |
| Pras, E | 2 |
| Arts, HJ | 1 |
| Eijsink, JJ | 1 |
| Hollema, H | 2 |
| Mom, CH | 1 |
| de Jong, S | 1 |
| de Vries, EG | 2 |
| de Bock, GH | 1 |
| van der Zee, AG | 1 |
| Moore, DH | 4 |
| Kim, CJ | 1 |
| Song, TJ | 1 |
| Kim, MK | 2 |
| Lee, JH | 4 |
| Lin, JT | 1 |
| Shih, SC | 1 |
| Chang, TH | 1 |
| Chang, CS | 1 |
| Ruggieri, V | 1 |
| Massaccesi, M | 2 |
| Salutari, V | 1 |
| Chitapanarux, I | 2 |
| Phromratanapongse, P | 1 |
| Hsieh, CY | 1 |
| Sukthomya, V | 1 |
| Forrest, JL | 1 |
| Ackerman, I | 2 |
| Barbera, L | 1 |
| Barnes, EA | 1 |
| Davidson, M | 1 |
| Kiss, A | 1 |
| Thomas, G | 5 |
| Kim, YB | 2 |
| Kim, HJ | 2 |
| Hasselle, MD | 1 |
| Rose, BS | 2 |
| Kochanski, JD | 1 |
| Nath, SK | 1 |
| Bafana, R | 1 |
| Yashar, CM | 2 |
| Hasan, Y | 1 |
| Roeske, JC | 1 |
| Mundt, AJ | 3 |
| Petrillo, M | 2 |
| Lee, JY | 1 |
| Kim, YH | 1 |
| Kim, MJ | 1 |
| Tian, ZZ | 1 |
| Liu, ML | 1 |
| Zhu, XH | 1 |
| Zhao, R | 1 |
| Yue, YJ | 1 |
| Chen, XH | 1 |
| Nam, HR | 2 |
| Chang, AJ | 1 |
| Richardson, S | 1 |
| Grigsby, PW | 8 |
| Schwarz, JK | 1 |
| Errihani, H | 1 |
| M'rabti, H | 1 |
| Ismaili, N | 1 |
| Inrhaoun, H | 1 |
| Elghissassi, I | 1 |
| Lee, YS | 1 |
| Park, EK | 1 |
| Yoshida, Y | 1 |
| Sato, K | 2 |
| Katayama, K | 1 |
| Yamaguchi, A | 1 |
| Imamura, Y | 1 |
| Kotsuji, F | 1 |
| Ali, S | 1 |
| McCaffrey, R | 1 |
| Bahtiyar, M | 1 |
| Kohorn, EI | 2 |
| Chambers, JT | 2 |
| Schwartz, PE | 2 |
| Chambers, SK | 2 |
| Giorda, G | 1 |
| Boz, G | 1 |
| Gadducci, A | 1 |
| Lucia, E | 1 |
| De Piero, G | 1 |
| De Paoli, A | 1 |
| Innocente, R | 1 |
| Trovò, M | 1 |
| Sorio, R | 1 |
| Campagnutta, E | 1 |
| Chen, CC | 1 |
| Lin, JC | 2 |
| Jan, JS | 2 |
| Ho, SC | 1 |
| Zheng, M | 1 |
| Huang, L | 1 |
| Liu, JH | 2 |
| Xiong, Y | 1 |
| Li, JD | 2 |
| Huang, X | 1 |
| He, L | 1 |
| Ren, YF | 1 |
| Wang, HY | 1 |
| Lin, YJ | 1 |
| Zhen, YZ | 1 |
| Zhao, YF | 1 |
| Wei, J | 1 |
| Hu, G | 1 |
| Song, S | 1 |
| Song, C | 1 |
| Wu, HG | 1 |
| Ha, SW | 1 |
| Zhang, M | 1 |
| Xu, HD | 1 |
| Pan, SD | 1 |
| Lin, S | 1 |
| Yue, JH | 1 |
| Liu, JR | 1 |
| Hwang, JH | 1 |
| Seo, SS | 1 |
| Kang, S | 1 |
| Gong, L | 1 |
| Lou, JY | 1 |
| Wang, P | 2 |
| Zhang, JW | 2 |
| Liu, H | 2 |
| Peng, ZL | 2 |
| Sanguanrungsirikul, S | 1 |
| Wang, PL | 1 |
| Cheng, YB | 1 |
| Kuerban, G | 1 |
| Cilla, S | 1 |
| Lucidi, A | 2 |
| Takara, K | 1 |
| Shin, Y | 1 |
| Obata, Y | 1 |
| Kitada, N | 1 |
| Ohnishi, N | 1 |
| Yokoyama, T | 1 |
| Okamoto, H | 1 |
| Kawamura, K | 1 |
| Kobayashi, Y | 2 |
| Sekiya, T | 1 |
| Kim, TE | 1 |
| Park, BJ | 1 |
| Kwack, HS | 1 |
| Kwon, JY | 1 |
| Yoon, SC | 1 |
| Liang, Y | 1 |
| Cornell, M | 1 |
| Hoh, CK | 1 |
| Lawson, JD | 1 |
| Einck, J | 1 |
| Saenz, C | 1 |
| Fanta, P | 1 |
| Bydder, GM | 1 |
| Iannone, V | 1 |
| Wang, CC | 1 |
| Lai, CH | 1 |
| Huang, YT | 1 |
| Chao, A | 1 |
| Chou, HH | 1 |
| Hong, JH | 1 |
| Yoon, MS | 1 |
| Kim, J | 1 |
| Wang, D | 1 |
| Ren, T | 1 |
| Wan, XR | 1 |
| Feng, FZ | 1 |
| Folkert, MR | 1 |
| Shih, KK | 1 |
| Abu-Rustum, NR | 2 |
| Jewell, E | 1 |
| Kollmeier, MA | 1 |
| Makker, V | 1 |
| Barakat, RR | 1 |
| Alektiar, KM | 1 |
| González Sánchez, JL | 1 |
| Flores Murrieta, G | 1 |
| Chávez Brambila, J | 1 |
| Deolarte Manzano, JM | 1 |
| Andrade Manzano, AF | 1 |
| Nguyen, D | 1 |
| Chauveinc, L | 1 |
| Cosset, JM | 1 |
| Clough, KB | 1 |
| Beuzeboc, P | 1 |
| Mouret-Fourme, E | 1 |
| Guyonnet, M | 1 |
| Brickelmaier, M | 1 |
| Carmillo, A | 1 |
| Goelz, S | 1 |
| Barsoum, J | 1 |
| Qin, XQ | 1 |
| Kamata, M | 1 |
| Matsumoto, A | 1 |
| Furutani, K | 1 |
| Ito, Y | 1 |
| O'Toole, SA | 1 |
| Sheppard, BL | 1 |
| McGuinness, EP | 1 |
| Gleeson, NC | 1 |
| Yoneda, M | 1 |
| Bonnar, J | 1 |
| Hattori, K | 2 |
| Kohchi, Y | 1 |
| Oikawa, N | 1 |
| Suda, H | 1 |
| Ura, M | 1 |
| Ishikawa, T | 1 |
| Miwa, M | 2 |
| Endoh, M | 1 |
| Eda, H | 1 |
| Tanimura, H | 1 |
| Kawashima, A | 1 |
| Horii, I | 1 |
| Ishitsuka, H | 2 |
| Shimma, N | 1 |
| Sangruchi, S | 1 |
| Kongthanarat, Y | 1 |
| Tangkaratt, S | 1 |
| Visetsiri, E | 1 |
| Mo, B | 1 |
| Pater, A | 1 |
| Saga, Y | 1 |
| Suzuki, M | 3 |
| Mizukami, H | 1 |
| Kohno, T | 1 |
| Takei, Y | 1 |
| Fukushima, M | 1 |
| Ozawa, K | 1 |
| Ghaemmaghami, F | 1 |
| Behtash, N | 1 |
| Yarandi, F | 1 |
| Moosavi, A | 1 |
| Modares, M | 1 |
| Toogeh, G | 1 |
| Khanafshar, N | 1 |
| Kashima, N | 1 |
| Ueda, M | 4 |
| Kanazawa, J | 1 |
| SULLIVAN, RD | 1 |
| NORCROSS, JW | 1 |
| WATKINS, E | 1 |
| MALKASIAN, GD | 5 |
| DECKER, DG | 5 |
| MUSSEY, E | 2 |
| JOHNSON, CE | 2 |
| REITEMEIER, RJ | 1 |
| MOERTEL, CG | 1 |
| BLACKBURN, CM | 1 |
| MOORE, JG | 1 |
| VANCAMPENHOUT, JL | 1 |
| BRANDKAMP, WW | 1 |
| CHAN, DP | 1 |
| HO, JH | 1 |
| WOO, AW | 1 |
| CENTARO, A | 1 |
| GASPARRI, F | 1 |
| MAIJNELLI, M | 2 |
| PERITI, P | 2 |
| HELSPER, JT | 1 |
| DEMOSS, EV | 1 |
| ANSFIELD, FJ | 1 |
| HULKA, JF | 1 |
| BISEL, HF | 1 |
| CAVANAGH, D | 4 |
| MARTIN, DS | 2 |
| FERGUSON, JH | 1 |
| HERNANDEZ-ROMAN, P | 1 |
| Long, HJ | 1 |
| Semiglazov, VF | 1 |
| Semiglazov, VV | 1 |
| Kosnikov, AG | 1 |
| Jiang, K | 1 |
| Delarue, FL | 1 |
| Sebti, SM | 1 |
| Suzuki, Y | 2 |
| Terauchi, M | 1 |
| Ino, K | 1 |
| Mizutani, S | 1 |
| Winter, K | 5 |
| Morris, M | 4 |
| Levenback, C | 3 |
| Cooper, J | 2 |
| Rotman, M | 4 |
| Gershenson, D | 2 |
| Mutch, DG | 5 |
| Yamamoto, K | 1 |
| Izumi, R | 3 |
| Nakajima, H | 2 |
| Ohashi, K | 1 |
| Kudo, R | 1 |
| Okuda, H | 1 |
| Takahashi, T | 1 |
| Origasa, H | 1 |
| Sugimori, H | 3 |
| Lerouge, D | 1 |
| Uzan, S | 1 |
| Jannet, D | 1 |
| Moureau-Zabotto, L | 1 |
| Genestie, C | 1 |
| Antoine, M | 1 |
| Jamali, M | 1 |
| O'Boyle, K | 1 |
| Viegas, CM | 1 |
| Araujo, CM | 1 |
| Dantas, MA | 1 |
| Froimtchuk, M | 1 |
| Oliveira, JA | 1 |
| Marchiori, E | 1 |
| Souhami, L | 2 |
| Hirabayashi, K | 1 |
| Kobayashi, M | 1 |
| Numa, F | 1 |
| Ito, T | 2 |
| Distefano, M | 4 |
| Zannoni, G | 1 |
| Manfredi, R | 2 |
| Mangiacotti, MG | 1 |
| Motoyama, S | 1 |
| Hamana, S | 1 |
| Ku, Y | 1 |
| Laoag-Fernandez, JB | 1 |
| Deguchi, M | 1 |
| Yoshida, S | 1 |
| Tominaga, M | 1 |
| Iwasaki, T | 1 |
| Ohara, N | 1 |
| Maruo, T | 1 |
| Yim, EK | 1 |
| Bae, JS | 1 |
| Namkoong, SE | 1 |
| Um, SJ | 1 |
| Cadron, I | 1 |
| Jakobsen, A | 2 |
| Vergote, I | 2 |
| Ryu, HS | 1 |
| Chun, M | 1 |
| Chang, KH | 1 |
| Chang, HJ | 1 |
| Lee, JP | 1 |
| Toita, T | 2 |
| Uno, T | 2 |
| Shinoda, A | 1 |
| Ogawa, K | 1 |
| Mitsuhashi, N | 1 |
| Maebayashi, K | 1 |
| Kawaguchi, A | 1 |
| Inoue, T | 1 |
| Teshima, T | 1 |
| Borowsky, ME | 2 |
| Elliott, KS | 2 |
| Pezzullo, JC | 1 |
| Santoso, P | 1 |
| Choi, W | 1 |
| Choi, K | 1 |
| Abulafia, O | 1 |
| Ivanov, S | 2 |
| Gaffney, DK | 4 |
| Fuhrman, C | 1 |
| Flinner, R | 1 |
| Greven, K | 3 |
| Ryu, J | 3 |
| Forbes, A | 1 |
| Kerlin, K | 1 |
| Nichols, RC | 1 |
| Zempolich, K | 1 |
| Jenkins, AD | 1 |
| Ramondetta, LM | 2 |
| Johnston, T | 1 |
| Wolf, JK | 1 |
| Brown, J | 1 |
| Atkinson, EN | 1 |
| Stokes, Z | 1 |
| Symonds, P | 1 |
| Habeshaw, T | 1 |
| Reed, N | 1 |
| Curto, J | 1 |
| Joynson, C | 1 |
| Chan, S | 2 |
| Saxena, A | 1 |
| Yashar, C | 1 |
| Taylor, DD | 1 |
| Gercel-Taylor, C | 1 |
| Zhang, CS | 1 |
| Cao, ZY | 1 |
| Windschall, A | 1 |
| Ott, OJ | 1 |
| Sauer, R | 2 |
| Strnad, V | 1 |
| Lopez-Graniel, C | 1 |
| Dolores, R | 1 |
| Cetina, L | 1 |
| Gonzalez, A | 1 |
| Cantu, D | 1 |
| Chanona, J | 1 |
| Uribe, J | 1 |
| Candelaria, M | 1 |
| Brom, R | 1 |
| de la Garza, J | 1 |
| Duenas-Gonzalez, A | 1 |
| Houvenaeghel, G | 3 |
| Lelievre, L | 1 |
| Gonzague-Casabianca, L | 1 |
| Buttarelli, M | 1 |
| Moutardier, V | 1 |
| Goncalves, A | 1 |
| Resbeut, M | 5 |
| Calkins, A | 1 |
| Bundy, BN | 5 |
| Parham, G | 1 |
| Lucci, JA | 2 |
| Monk, BJ | 2 |
| O'Connor, DM | 2 |
| Kawase, S | 1 |
| Okuda, T | 1 |
| Ikeda, M | 3 |
| Ishihara, S | 1 |
| Yanagawa, S | 1 |
| Ishigaki, T | 1 |
| Tanaka, T | 2 |
| Bai, T | 1 |
| Yukawa, K | 2 |
| Umesaki, N | 2 |
| Li, QS | 1 |
| Zhang, XQ | 1 |
| Li, DP | 1 |
| Sheng, XG | 1 |
| Du, XL | 1 |
| Song, QQ | 1 |
| Wright, JD | 1 |
| Viviano, D | 1 |
| Powell, MA | 1 |
| Gibb, RK | 1 |
| Rader, JS | 1 |
| Morganti, A | 2 |
| Paglia, A | 2 |
| Lorusso, D | 1 |
| Ait Menguellet, S | 1 |
| Collinet, P | 1 |
| Houfflin Debarge, V | 1 |
| Nayama, M | 1 |
| Vinatier, D | 1 |
| Leroy, JL | 1 |
| Kreĭnina, IuM | 1 |
| Titova, VA | 1 |
| Shipilova, AN | 1 |
| Povarova, EV | 1 |
| Shevchenko, LN | 1 |
| Cai, HB | 1 |
| Chen, HZ | 1 |
| Yin, HH | 1 |
| Malka, ES | 1 |
| Scudder, SA | 1 |
| Leiserowitz, GS | 1 |
| Russell, AH | 1 |
| Sin, JI | 1 |
| Ye, GW | 1 |
| Shin, IH | 1 |
| Lee, TS | 1 |
| Cho, JH | 1 |
| Keum, KC | 1 |
| Lee, CG | 1 |
| Seong, J | 1 |
| Suh, CO | 3 |
| Kim, GE | 3 |
| Danso, D | 1 |
| Lyons, F | 1 |
| Bradbeer, C | 1 |
| Dhadda, AS | 1 |
| Zhang, C | 1 |
| Beckermann, B | 1 |
| Kallifatidis, G | 1 |
| Rittgen, W | 1 |
| Edler, L | 1 |
| Büchler, P | 1 |
| Debatin, KM | 1 |
| Büchler, MW | 1 |
| Friess, H | 1 |
| Herr, I | 1 |
| Martinelli, E | 1 |
| Zannoni, GF | 1 |
| Ferlini, C | 1 |
| Garcia, AA | 1 |
| Blessing, JA | 4 |
| Darcy, KM | 1 |
| Lenz, HJ | 1 |
| Zhang, W | 1 |
| Hannigan, E | 1 |
| Dicker, AP | 2 |
| Miller, B | 2 |
| Avizonis, V | 2 |
| Fromm, M | 2 |
| Kozbagarova, RG | 1 |
| Tumabaeva, SD | 1 |
| Khoury-Collado, F | 1 |
| Bowes, RJ | 1 |
| Jhamb, N | 1 |
| Aghajanian, C | 1 |
| Kim, WY | 1 |
| Xiao, Y | 1 |
| Shi, HL | 1 |
| Feng, YL | 1 |
| Li, MD | 1 |
| Geisler, JP | 1 |
| Manahan, KJ | 1 |
| Rippy, JK | 1 |
| Lim, DH | 1 |
| Han, Y | 1 |
| Park, HC | 1 |
| Ahn, YC | 1 |
| Marnitz, S | 1 |
| Köhler, C | 1 |
| Roth, C | 1 |
| Füller, J | 1 |
| Bischoff, A | 1 |
| Wendt, T | 1 |
| Schneider, A | 1 |
| Budach, V | 1 |
| Torres, MA | 1 |
| Thames, HD | 1 |
| Levenback, CF | 1 |
| Wolfson, AH | 1 |
| Crook, W | 1 |
| Krishan, A | 1 |
| Markoe, AM | 1 |
| Wada, Y | 1 |
| Ohara, T | 1 |
| Okuda, Y | 1 |
| Suzuki, N | 1 |
| Kiguchi, K | 1 |
| Ishizuka, B | 1 |
| Bai, P | 1 |
| Zhang, R | 1 |
| Li, XG | 1 |
| Ma, SK | 1 |
| Wu, LY | 1 |
| Zhang, WH | 1 |
| Benjapibal, M | 1 |
| Thirapakawong, C | 1 |
| Leelaphatanadit, C | 1 |
| Therasakvichya, S | 1 |
| Inthasorn, P | 1 |
| Han, C | 1 |
| Kong, WM | 1 |
| Sakata, K | 1 |
| Sakurai, H | 1 |
| Katoh, S | 1 |
| Ohno, T | 1 |
| Kataoka, M | 1 |
| Tanaka, E | 1 |
| Kaneyasu, Y | 5 |
| Harima, Y | 1 |
| Nakano, T | 1 |
| Gorgun, B | 1 |
| Goplerud, DR | 2 |
| Watne, AL | 1 |
| Machida, Y | 2 |
| Masuda, H | 2 |
| Fujiyama, N | 2 |
| Iwata, M | 2 |
| Sumiyoshi, Y | 1 |
| Shiojima, Y | 1 |
| Suda, T | 1 |
| Kikyo, T | 1 |
| Nagai, K | 1 |
| Pawlicki, M | 1 |
| Janowska, E | 1 |
| Wiernik-Strzeszyńska, E | 1 |
| Kawagoe, K | 1 |
| Iijima, S | 1 |
| Sasaki, J | 1 |
| Miyoshi, T | 1 |
| Ogawa, S | 1 |
| Nobuhara, M | 1 |
| Namba, M | 1 |
| Oberfield, RA | 1 |
| Nagai, S | 2 |
| Sawada, T | 1 |
| Kawai, Y | 2 |
| Hirano, H | 2 |
| Taniguchi, H | 2 |
| Tamaishi, Y | 1 |
| Nishimura, K | 1 |
| Asakura, T | 1 |
| Ri, T | 1 |
| Uematsu, A | 2 |
| Sugiyama, Y | 2 |
| Okazaki, H | 2 |
| Hasegawa, T | 2 |
| Fujimori, T | 1 |
| Katayama, S | 1 |
| Sakaguchi, K | 1 |
| Hayashi, Y | 2 |
| Nakagiri, Y | 2 |
| Ishii, Y | 2 |
| Fukui, H | 2 |
| Kohno, I | 2 |
| Endoh, S | 1 |
| Chin, N | 1 |
| Rin, K | 1 |
| Dembo, A | 3 |
| Beale, F | 2 |
| Bean, H | 2 |
| Bush, R | 2 |
| Herman, J | 1 |
| Pringle, J | 2 |
| Rawlings, G | 3 |
| Sturgeon, J | 1 |
| Fine, S | 1 |
| Noda, T | 1 |
| Kamamoto, Y | 1 |
| Saitoh, S | 1 |
| Nakanishi, A | 1 |
| Ando, Y | 1 |
| Tsuji, Y | 1 |
| Yoh, S | 1 |
| Moriyama, I | 1 |
| Ichijo, M | 1 |
| Hatae, M | 1 |
| Terahara, M | 1 |
| Hokanishi, H | 1 |
| Hareyama, H | 1 |
| Ishizaki, Y | 1 |
| Ohkubo, H | 1 |
| Kanemoto, T | 1 |
| Valet, G | 1 |
| Warnecke, HH | 1 |
| Kahle, H | 1 |
| Sawada, M | 1 |
| Matsui, Y | 1 |
| Okudaira, Y | 2 |
| Bobchev, T | 1 |
| Tsekov, V | 1 |
| Petrilli, ES | 1 |
| Townsend, DE | 1 |
| Morrow, CP | 2 |
| Nakao, CY | 1 |
| Kidera, Y | 1 |
| Tanaka, M | 1 |
| Jimi, S | 1 |
| Watanabe, E | 1 |
| Kato, Y | 1 |
| Morita, T | 1 |
| Shigyo, R | 1 |
| Yamashita, H | 1 |
| Nishimura, A | 1 |
| Kawakami, M | 1 |
| Toyota, Y | 1 |
| Tsukamoto, N | 2 |
| Matsuyama, T | 1 |
| Yamada, E | 1 |
| Green, SJ | 1 |
| Edmonson, JH | 1 |
| Jefferies, JA | 1 |
| Webb, MJ | 2 |
| Chan, WK | 1 |
| Aroney, RS | 1 |
| Levi, JA | 2 |
| Tattersall, MH | 2 |
| Fox, RM | 1 |
| Woods, RL | 1 |
| Pride, GL | 1 |
| Chuprevich, TW | 1 |
| Sorbe, B | 1 |
| Frankendal, B | 1 |
| Calabro-Jones, PM | 1 |
| Byfield, JE | 2 |
| Ward, JF | 1 |
| Sharp, TR | 1 |
| Horno Gimeno, M | 1 |
| Daly, JW | 2 |
| Ellis, GF | 1 |
| Gerinshteĭn, IG | 1 |
| Kislichenko, VA | 1 |
| Tarkhanova, MV | 1 |
| Pashchenko, NS | 1 |
| Kolesnikova, GS | 1 |
| Gonzales-de Léon, C | 1 |
| Lippman, SM | 1 |
| Kudelka, AP | 1 |
| Edwards, CL | 1 |
| Kavanagh, JJ | 4 |
| Lamb, L | 1 |
| Delanian, S | 1 |
| Housset, M | 1 |
| Maulard-Durdux, C | 1 |
| Taurelle, R | 1 |
| Baillet, F | 1 |
| Tonusin, A | 1 |
| Sukthomya, W | 1 |
| Changwiwit, W | 1 |
| Nimmolrat, A | 1 |
| Wada, K | 1 |
| Koyama, M | 1 |
| Iijima, Y | 1 |
| Inagaki, M | 1 |
| Hirota, Y | 1 |
| Hongo, J | 1 |
| Ozaki, M | 2 |
| Miyazaki, K | 2 |
| Mizutani, H | 1 |
| Katabuchi, H | 1 |
| Fukuma, K | 1 |
| Fujisaki, S | 1 |
| Okamura, H | 1 |
| Woolfson, AD | 2 |
| McCafferty, DF | 2 |
| McCarron, PA | 2 |
| Price, JH | 2 |
| Imai, T | 1 |
| Kodama, S | 1 |
| Yanase, T | 1 |
| Ikarashi, H | 1 |
| Kazama, Y | 1 |
| Tanaka, K | 2 |
| Aida, I | 1 |
| Ohwada, M | 2 |
| Sato, I | 1 |
| Tamura, T | 1 |
| Kasuga, Y | 1 |
| Fanning, J | 1 |
| Ladd, C | 1 |
| Hilgers, RD | 1 |
| Sasson, Z | 1 |
| Morgan, CD | 1 |
| Wang, B | 1 |
| MacKenzie, B | 1 |
| Platts, ME | 1 |
| Stornes, I | 1 |
| Mejlholm, I | 1 |
| Davidson, JA | 1 |
| Maruyama, Y | 1 |
| Bowen, MG | 1 |
| Van Nagell, JR | 1 |
| Gallion, HH | 1 |
| DePriest, P | 1 |
| Wierzbicki, J | 1 |
| Cowen, D | 1 |
| Viens, P | 2 |
| Noirclerc, M | 2 |
| Perez, T | 1 |
| Gouvernet, J | 1 |
| Delpero, JR | 2 |
| Gamerre, M | 2 |
| Boubli, L | 2 |
| Kato, T | 1 |
| Yakushiji, M | 1 |
| Yamabe, T | 2 |
| Hidaki, T | 1 |
| Tazaki, T | 1 |
| d'Ercole, C | 1 |
| Teshima, K | 1 |
| Noda, K | 3 |
| Yamagata, S | 1 |
| Sugawa, T | 1 |
| Okamura, S | 2 |
| Kubo, H | 1 |
| Sugimoto, O | 2 |
| Xiao, XH | 1 |
| Khalil, AM | 1 |
| Khatib, RA | 1 |
| Mufarrij, AA | 1 |
| Tawil, AN | 1 |
| Issa, PY | 1 |
| Husseinzadeh, N | 1 |
| Shrake, P | 1 |
| DeEulis, T | 1 |
| Rowley, K | 1 |
| Aron, B | 1 |
| Löwhagen, GB | 1 |
| Von Krogh, G | 1 |
| Bistoletti, P | 1 |
| Persson, G | 1 |
| Rylander, E | 1 |
| Park, TK | 2 |
| Lee, SK | 1 |
| Kim, SN | 2 |
| Hwang, TS | 1 |
| Loh, JK | 1 |
| Macia, M | 1 |
| Novo, A | 1 |
| Ces, J | 1 |
| Gonzalez, M | 1 |
| Huidobro, C | 1 |
| Yuste, J | 1 |
| Diab, T | 1 |
| Narimatsu, A | 2 |
| Okada, O | 2 |
| Denehy, TR | 1 |
| Eastman, R | 1 |
| SanFilippo, L | 1 |
| Gregori, CA | 1 |
| Breen, JL | 1 |
| Ho, ES | 1 |
| Yang, CH | 1 |
| Liu, FS | 1 |
| John, M | 4 |
| Flam, M | 4 |
| Caplan, R | 1 |
| Quivey, J | 1 |
| Steinfeld, A | 1 |
| Russell, A | 1 |
| Sundfør, K | 2 |
| Tropé, CG | 1 |
| Högberg, T | 1 |
| Onsrud, M | 1 |
| Koern, J | 1 |
| Simonsen, E | 1 |
| Bertelsen, K | 1 |
| Westberg, R | 1 |
| Hsu, WL | 1 |
| Shueng, PW | 1 |
| Jen, YM | 1 |
| Wu, CJ | 1 |
| Liu, HS | 1 |
| Su, CC | 1 |
| Hwang, JM | 1 |
| Kondoh, H | 1 |
| Niwa, K | 1 |
| Itoh, N | 1 |
| Murase, T | 1 |
| Morishita, S | 1 |
| Imai, A | 1 |
| Tamaya, T | 1 |
| Christie, DR | 1 |
| Bull, CA | 1 |
| Gebski, V | 1 |
| Langlands, AO | 2 |
| Kaern, J | 5 |
| Tropé, C | 5 |
| Sundfoer, K | 1 |
| Kristensen, GB | 1 |
| Look, KY | 3 |
| Gallup, DG | 1 |
| Lentz, SS | 1 |
| Willemse, PH | 1 |
| Boonstra, H | 1 |
| Heesters, MA | 1 |
| Szabó, BG | 1 |
| de Bruijn, HW | 1 |
| Aalders, JG | 1 |
| Okawa, MK | 3 |
| Kokubo, N | 2 |
| Takemoto, M | 1 |
| Karasawa, K | 3 |
| Fukuhara, N | 2 |
| Toda, J | 3 |
| Okawa, T | 4 |
| Dimpfl, T | 1 |
| Stumpfe, M | 2 |
| Baltzer, J | 2 |
| Genz, T | 1 |
| Sidhu, HK | 1 |
| Biggart, D | 1 |
| Thompson, W | 1 |
| Heise, C | 1 |
| Sampson-Johannes, A | 1 |
| Williams, A | 1 |
| McCormick, F | 1 |
| Von Hoff, DD | 1 |
| Kirn, DH | 1 |
| Kumagai, K | 2 |
| Ueki, K | 2 |
| Inoki, C | 1 |
| Orino, I | 1 |
| Ueki, M | 3 |
| Fishman, A | 1 |
| Chiu, JK | 1 |
| Girtanner, RE | 1 |
| Dennis, W | 1 |
| Carpenter, LS | 1 |
| Lu, HH | 1 |
| Woo, SY | 1 |
| Kerley, JM | 1 |
| Kaplan, AL | 1 |
| Kucera, PR | 1 |
| Deppe, G | 3 |
| Reddy, S | 2 |
| Rakovitch, E | 1 |
| Fyles, AW | 1 |
| Pintilie, M | 1 |
| Leung, PM | 1 |
| Fushiki, H | 1 |
| Hidaka, T | 1 |
| Hori, S | 1 |
| Fujimura, M | 1 |
| Yamakawa, Y | 1 |
| Rowinsky, EK | 1 |
| Valea, FA | 1 |
| McGehee, R | 1 |
| Manetta, A | 2 |
| Webster, KD | 1 |
| Andersen, WA | 1 |
| Franssen, E | 1 |
| Balogh, J | 1 |
| Fyles, A | 2 |
| Levin, W | 1 |
| Schulz-Wendtland, R | 1 |
| Krämer, S | 1 |
| Säbel, M | 1 |
| Heller, F | 1 |
| Keilholz, L | 1 |
| Jäger, W | 1 |
| Lang, N | 1 |
| Bautz, W | 1 |
| Lu, JD | 1 |
| Kim, RY | 2 |
| Konishi, I | 1 |
| Nanbu, K | 1 |
| Mandai, M | 1 |
| Tsuruta, Y | 1 |
| Kataoka, N | 1 |
| Nagata, Y | 1 |
| Mori, T | 2 |
| Lindner, H | 1 |
| Varia, MA | 1 |
| Mannel, R | 1 |
| Averette, HE | 1 |
| Connelly, P | 1 |
| Rotmensch, J | 2 |
| Waggoner, S | 1 |
| Quiet, C | 1 |
| Fleming, G | 1 |
| Lu, J | 1 |
| Stevens, RE | 1 |
| Gershenson, DM | 1 |
| Watkins, EB | 1 |
| Thigpen, JT | 1 |
| Maiman, MA | 1 |
| Clarke-Pearson, DL | 2 |
| Insalaco, S | 1 |
| Paulsen, T | 1 |
| Monaghan, J | 1 |
| Sause, W | 1 |
| Malfetano, JH | 2 |
| Hannigan, EV | 2 |
| Fowler, WC | 2 |
| Liao, SY | 1 |
| Jurado, M | 2 |
| Martínez-Monge, R | 2 |
| García-Foncillas, J | 1 |
| Azinovic, I | 1 |
| Aristu, J | 1 |
| López-García, G | 2 |
| Brugarolas, A | 1 |
| Marth, C | 1 |
| Sundfor, K | 1 |
| Maneo, A | 1 |
| Landoni, F | 1 |
| Cormio, G | 1 |
| Colombo, A | 1 |
| Placa, F | 1 |
| Pellegrino, A | 1 |
| Mangioni, C | 1 |
| Chaney, AW | 1 |
| Logsdon, MD | 1 |
| Wharton, JT | 1 |
| Grogan, M | 1 |
| Melamed, I | 1 |
| Wong, FL | 1 |
| Pearcey, RG | 1 |
| Joseph, PK | 1 |
| Portelance, L | 1 |
| Crook, J | 1 |
| Jones, KD | 1 |
| Vishnevskaia, EE | 1 |
| Kosenko, IA | 1 |
| Kita, M | 1 |
| Katsui, K | 1 |
| Kono, M | 1 |
| Kojima, N | 1 |
| Himei, K | 1 |
| Isobe, M | 1 |
| Yamanouchi, E | 1 |
| Haie-Meder, C | 2 |
| Fervers, B | 1 |
| Chauvergne, J | 1 |
| Fondrinier, E | 1 |
| Lhommé, C | 2 |
| Guastalla, JP | 1 |
| Maiman, M | 1 |
| Watts, DH | 1 |
| Andersen, J | 1 |
| Clax, P | 1 |
| Merino, M | 1 |
| Kendall, MA | 1 |
| Ito, H | 1 |
| Ochiai, K | 1 |
| Peters, WA | 1 |
| Liu, PY | 1 |
| Barrett, RJ | 1 |
| Stock, RJ | 1 |
| Berek, JS | 1 |
| Grigsby, P | 1 |
| Gordon, W | 1 |
| Alberts, DS | 2 |
| Kim, SW | 1 |
| Boronow, RC | 1 |
| Mancuso, S | 1 |
| Benedetti Panici, P | 1 |
| Favale, B | 1 |
| Greggi, S | 1 |
| Tortoreto, F | 1 |
| Dunst, J | 3 |
| Kitaura, K | 1 |
| Kusada, O | 1 |
| Mochizuki, Y | 1 |
| Yamada, N | 1 |
| Terai, Y | 1 |
| de Crevoisier, R | 1 |
| Morice, P | 1 |
| Cao, Z | 1 |
| Zhang, D | 1 |
| Peng, Z | 1 |
| Hanna, L | 1 |
| Aoki, Y | 1 |
| Sato, T | 1 |
| Watanabe, M | 1 |
| Sasaki, M | 1 |
| Tsuneki, I | 1 |
| Aristu, JJ | 1 |
| Moreno, M | 1 |
| Cambeiro, M | 1 |
| Pérez-Ochoa, A | 1 |
| Alcazar, JL | 1 |
| Herzog, TJ | 1 |
| Heydon, K | 1 |
| Eifel, P | 1 |
| Ogino, M | 1 |
| Minoura, S | 1 |
| Haensgen, G | 1 |
| Shimizu, Y | 3 |
| Hänsgen, G | 1 |
| Kuhnt, T | 1 |
| Pigorsch, S | 1 |
| Strauss, H | 1 |
| Berclaz, G | 1 |
| Gerber, E | 1 |
| Beer, K | 1 |
| Aebi, S | 1 |
| Greiner, R | 1 |
| Dreher, E | 1 |
| Buser, K | 1 |
| Podzamczer, D | 1 |
| Miralles, P | 1 |
| La Calle Md, Md | 1 |
| Zarco, C | 1 |
| Berenguer, J | 1 |
| López Aldeguer, J | 1 |
| Valencia, E | 1 |
| Rubio, R | 1 |
| Ribera, JM | 1 |
| Gibbons, SK | 1 |
| Keys, HM | 1 |
| Miki, Y | 1 |
| Kawatsu, T | 1 |
| Matsuda, H | 1 |
| Yamada, T | 2 |
| Kahata, A | 1 |
| Forney, JP | 1 |
| DiSaia, PJ | 3 |
| Futoran, RJ | 1 |
| Guthrie, D | 1 |
| Way, S | 1 |
| Wasserman, TH | 1 |
| Carter, SK | 1 |
| Piver, MS | 3 |
| Barlow, JJ | 2 |
| Xynos, FP | 1 |
| Tsukada, Y | 1 |
| Gamarra, M | 1 |
| Sandecki, A | 1 |
| Il'inskaia, EG | 1 |
| Pankov, AK | 1 |
| Sidorenko, IuS | 1 |
| Birbraer, VM | 1 |
| Bordiushkov, IuN | 1 |
| Jorgensen, EO | 2 |
| Marzotko, F | 2 |
| Krafft, W | 3 |
| Preibsch, W | 1 |
| Schröder, M | 1 |
| Sharma, K | 1 |
| Tripathi, N | 1 |
| Mathur, RK | 1 |
| Mathur, V | 1 |
| Kling, AR | 1 |
| Wheeler, HR | 1 |
| Friedlander, M | 1 |
| Kefford, R | 1 |
| Dalley, D | 1 |
| Muss, HB | 1 |
| Partridge, EE | 1 |
| Drescher, CW | 1 |
| Reid, GC | 1 |
| Terada, K | 1 |
| Roberts, JA | 1 |
| Hopkins, MP | 1 |
| Perez-Tamayo, C | 1 |
| Schoeppel, SL | 1 |
| Reiter, Z | 1 |
| Ozes, ON | 1 |
| Tomson, S | 1 |
| Blatt, LM | 1 |
| Taylor, MW | 1 |
| Epperson, WJ | 1 |
| Kaufmann, M | 1 |
| Schmid, H | 1 |
| Junkermann, H | 1 |
| Schönig, T | 1 |
| von Fournier, D | 1 |
| Bastert, G | 1 |
| Nguyen, PD | 1 |
| John, B | 1 |
| Munoz, AK | 1 |
| Yazigi, R | 1 |
| Graham, M | 1 |
| Franklin, P | 1 |
| Roberts, WS | 3 |
| Hoffman, MS | 2 |
| Fiorica, JV | 1 |
| Greenberg, H | 2 |
| Finan, MA | 1 |
| Bloss, JD | 1 |
| Mannel, RS | 1 |
| Hyden, EC | 1 |
| Walker, JL | 1 |
| Berman, ML | 1 |
| Maassen, V | 1 |
| Sekiguchi, F | 1 |
| Akaza, H | 1 |
| Tokita, H | 1 |
| Nitta, K | 1 |
| Adachi, S | 1 |
| Kanazawa, K | 1 |
| Watanabe, Y | 1 |
| Takeuchi, K | 1 |
| Kinugasa, M | 1 |
| Sekiba, K | 3 |
| Kobashi, Y | 2 |
| Ohiwa, T | 1 |
| Odagiri, H | 1 |
| Chakalova, G | 1 |
| Karag'ozov, A | 1 |
| Marinova, L | 1 |
| Ralcheva, Ts | 1 |
| Khoury, GG | 1 |
| Bulman, AS | 1 |
| Joslin, CA | 1 |
| Rothwell, RI | 1 |
| Kemnitz, T | 1 |
| Glaser, F | 1 |
| Schirmer, A | 1 |
| Sikic, B | 1 |
| Malec, M | 1 |
| Hannigan, J | 1 |
| Phillips, T | 1 |
| Kjørstad, KE | 1 |
| Nordal, R | 1 |
| Vossli, S | 1 |
| Abeler, V | 2 |
| Sandvei, R | 1 |
| Heaton, D | 1 |
| Yordan, E | 1 |
| Bonomi, P | 2 |
| Lee, MS | 1 |
| Lincoln, S | 1 |
| Graham, J | 1 |
| Dolan, T | 1 |
| Miller, A | 1 |
| Phillips, A | 1 |
| Gadalla, T | 1 |
| Black, B | 2 |
| Arakawa, A | 1 |
| Kato, N | 1 |
| Asai, H | 1 |
| Yasui, Y | 1 |
| Suzumori, K | 2 |
| Yagami, Y | 1 |
| Teshima, H | 1 |
| Fujimoto, I | 1 |
| Hasumi, K | 2 |
| Masubuchi, K | 2 |
| Crumpler, LS | 1 |
| Iversen, T | 1 |
| Kjørstad, K | 1 |
| Weiss, GR | 1 |
| Green, S | 1 |
| Boutselis, JG | 1 |
| Surwit, EA | 1 |
| Wallace, DL | 1 |
| Silva, PD | 1 |
| Micha, JP | 1 |
| Silva, DG | 1 |
| Weng, ZY | 1 |
| Kawabata, M | 1 |
| Hosokawa, H | 1 |
| Katoh, K | 1 |
| Hardy, JR | 1 |
| Maclean, GD | 1 |
| Foote, GA | 1 |
| Harvey, VJ | 1 |
| Dziambor, U | 1 |
| Sarembe, B | 1 |
| Richter, P | 1 |
| Lotze, W | 1 |
| Lele, SB | 1 |
| Yabushita, H | 1 |
| Sawaguchi, K | 1 |
| Ueno, N | 1 |
| Hieda, S | 1 |
| Noguchi, M | 1 |
| Ishihara, M | 1 |
| Yamashita, K | 1 |
| Mitani, K | 1 |
| Morishita, Y | 1 |
| Inoue, K | 2 |
| Misaki, O | 1 |
| Okamoto, Y | 1 |
| Goto, M | 1 |
| Maeda, T | 2 |
| Cao, SS | 1 |
| Zhen, YS | 1 |
| Bryson, SC | 1 |
| LaPolla, JP | 1 |
| Townsend, PA | 1 |
| Hewitt, S | 1 |
| Blessing, J | 1 |
| Ball, H | 1 |
| Hanjani, P | 1 |
| Ngan, HY | 1 |
| Wong, LC | 1 |
| Chan, SY | 1 |
| Ma, HK | 1 |
| Sillman, FH | 1 |
| Sedlis, A | 1 |
| Boyce, JG | 1 |
| Krebs, HB | 2 |
| Schneider, V | 1 |
| Hurt, WG | 1 |
| Tanimura, T | 1 |
| Kaneshige, E | 1 |
| Fujiwara, K | 2 |
| Kono, I | 1 |
| Wittlinger, P | 1 |
| Podolsky, W | 1 |
| Padmanabhan, A | 2 |
| Mowry, PA | 2 |
| Kamiya, H | 1 |
| Sakai, K | 1 |
| Dembo, AJ | 1 |
| Bean, HA | 1 |
| Beale, FA | 1 |
| Pringle, JR | 1 |
| Depetrillo, D | 1 |
| Cooke, JK | 1 |
| Jian, S | 1 |
| Ludgate, SM | 1 |
| Crandon, AJ | 1 |
| Hudson, CN | 1 |
| Walker, Q | 1 |
| Evans, LS | 1 |
| Kersh, CR | 1 |
| Constable, WC | 1 |
| Taylor, PT | 1 |
| Chiara, S | 1 |
| Consoli, R | 1 |
| Falcone, A | 1 |
| Bruzzone, M | 1 |
| Foglia, G | 1 |
| Ragni, N | 1 |
| Conte, PF | 1 |
| Shiotani, M | 1 |
| Nishi, O | 1 |
| Sasaki, T | 1 |
| Yamada, M | 1 |
| Senekjian, EK | 1 |
| Javaheri, G | 1 |
| Herbst, AL | 1 |
| Miura, S | 1 |
| Sato, H | 1 |
| Azuma, T | 1 |
| Akiya, K | 2 |
| Barten, G | 1 |
| Payraudeau-Daoud, P | 1 |
| Ciraru-Vigneron, N | 1 |
| Bercau, G | 1 |
| Muray, JM | 1 |
| Mignot, L | 1 |
| Espie, M | 1 |
| Marty, M | 1 |
| Barrier, J | 1 |
| Wang, SL | 1 |
| Yajima, A | 1 |
| Tenjin, Y | 1 |
| Kurihara, S | 1 |
| Okada, K | 1 |
| Copeland, L | 1 |
| Praest, J | 1 |
| Klem, V | 1 |
| Fuller, AF | 1 |
| Krane, IM | 1 |
| Budzik, GP | 1 |
| Donahoe, PK | 1 |
| Nishiyama, M | 1 |
| Yanase, H | 1 |
| Sekiguchi, I | 1 |
| Tamada, T | 1 |
| Hughes, RR | 1 |
| Recher, L | 1 |
| Parry, N | 1 |
| Whitescarver, J | 1 |
| Briggs, L | 1 |
| Omura, GA | 1 |
| Papadimitriou, G | 1 |
| Razis, D | 1 |
| Panopoulos, C | 1 |
| Lappas, C | 1 |
| Gnafakis, N | 1 |
| Kissel, P | 1 |
| Bessot, M | 1 |
| Duprez, A | 1 |
| Dekster, LI | 1 |
| Bloomfield, RD | 1 |
| Ueda, G | 1 |
| Sato, Y | 1 |
| Hayakawa, K | 1 |
| Yoshinare, S | 1 |
| Yamazaki, M | 1 |
| Hsu, CT | 1 |
| Cheng, YS | 1 |
| Su, SC | 1 |
| Preibsche, W | 1 |
| Lewis, GC | 1 |
| Lee, YC | 1 |
| Smith, JP | 2 |
| Rutledge, F | 1 |
| Burns, BC | 1 |
| Soffar, S | 1 |
| Nugmanov, SN | 1 |
| Esenkulov, AE | 1 |
| Schwartz, GF | 1 |
| Green, HL | 1 |
| Bendon, ML | 1 |
| Graham, WP | 1 |
| Blakemore, WS | 1 |
| Randall, GE | 1 |
| Castro, JR | 1 |
| Lindberg, RD | 1 |
| Gulesserian, HP | 1 |
| Lawton, RL | 1 |
| Condon, RE | 1 |
| Kagan, AR | 1 |
| Jones, HW | 1 |
| Droegemueller, W | 1 |
| Makowski, EL | 1 |
| Hanham, IW | 1 |
| Newton, KA | 1 |
| Westbury, G | 1 |
| Al-Sarraf, M | 1 |
| Wong, P | 1 |
| Sardesai, S | 1 |
| Vaitkevicius, VK | 1 |
| Goolsby, CD | 1 |
| Skinner, OD | 1 |
| Gibbs, CE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Controlled Trial of the Efficacy of Adjuvant Chemotherapy in Patients With Residual Lesions After Concurrent Radiochemotherapy for Locally Advanced Cervical Cancer[NCT04409860] | 120 participants (Anticipated) | Interventional | 2020-05-26 | Recruiting | |||
| [NCT01849107] | 49 participants (Actual) | Interventional | 2013-04-30 | Completed | |||
| Prospective Study for the Validation of the Genetic Signature 354849 to Predict the Response to Standard Treatment in Patients With Locally Advanced Cervical Cancer[NCT04067882] | 189 participants (Anticipated) | Observational | 2019-09-30 | Recruiting | |||
| COnventional Radiography Based Intracavitary Brachytherapy (Standard Arm) Versus Magnetic Resonance Image Based BrAchyTherapy (Study Arm) in Locally Advanced Cervical Cancers: A Phase III Randomized Controlled Trial (COMBAT - Cervix Trial)[NCT03005743] | 1,050 participants (Anticipated) | Interventional | 2016-12-31 | Recruiting | |||
| A Randomized Comparison of Radiation vs Radiation Plus Weekly Cisplatin vs Radiation Plus PVI (Protracted Venous Infusion) 5-FU in Patients With Stage II-B, III-B, and IV-A Carcinoma of the Cervix With Negative Paraaortic Nodes[NCT00003078] | Phase 3 | 870 participants (Anticipated) | Interventional | 1997-10-31 | Completed | ||
| Phase II Trial of Weekly Carboplatin-Paclitaxel Adjuvant Chemotherapy After Intensity Modulated Extended-field Chemoradiation in the Treatment of Locally Advanced Cervical Cancer With Para-aortic Positive Nodes[NCT04016142] | Phase 2 | 21 participants (Actual) | Interventional | 2020-07-15 | Active, not recruiting | ||
| Safety and Efficacy of Gemcitabine Based Neoadjuvant Chemotherapy Followed by Chemoradiation in Locally Advanced Cervical Cancer Patients and Association With Human Equilibrative Nucleoside Transporter 1 (hENT1) Expression[NCT02309658] | Phase 2 | 50 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| A Phase I/II Study Of COX-2 Inhibitor, CELEBREX (CELECOXIB), And Chemoradiation In Patients With Locally Advanced Cervical Cancer[NCT00023660] | Phase 1/Phase 2 | 84 participants (Actual) | Interventional | 2001-08-31 | Completed | ||
| AVF3963s Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer[NCT00600210] | Phase 2 | 0 participants (Actual) | Interventional | 2008-01-31 | Withdrawn (stopped due to low patient accrual) | ||
| Randomized Phase III Clinical Trial of Weekly Versus Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer[NCT01561586] | Phase 3 | 374 participants (Anticipated) | Interventional | 2012-03-31 | Recruiting | ||
| A Phase 1/2a/3 Evaluation of the Safety and Efficacy of Adding AL3818 (Anlotinib, INN: Catequentinib), a Dual Receptor Tyrosine Kinase Inhibitor, to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallop[NCT02584478] | Phase 3 | 294 participants (Actual) | Interventional | 2015-12-31 | Active, not recruiting | ||
| "Phase III Clinical Trial: Evaluation of the Combination of TRANSKRIP ® Plus Carboplatin and Paclitaxel as First Line Chemotherapy on Survival of Patients With Recurrent - Persistent Cervical Cancer"[NCT02446652] | Phase 3 | 230 participants (Anticipated) | Interventional | 2015-07-31 | Not yet recruiting | ||
| A Limited Access Phase II Trial Of Capecitabine In Advanced, Persistent Or Recurrent Squamous Cell Carcinoma Of The Cervix[NCT00016926] | Phase 2 | 0 participants | Interventional | 2001-04-30 | Completed | ||
| Prospective, Randomised and Multi-centric Therapy Optimisation Study for Examining the Influence of Surgical Staging on the Oncological Results for Patients With Cervix Carcinoma of the FIGO Stages IIB-IV After Chemoradiation[NCT01049100] | 250 participants (Anticipated) | Interventional | 2009-04-30 | Recruiting | |||
| A Prospective Phase II Study of Prophylactic TPO Combined With Bone Marrow-Sparing Intensity-Modulated Radiotherapy to Reduce Platelet Inhibition in Patients With Esophageal Cancer Undergoing Concurrent Chemoradiotherapy[NCT05944809] | Phase 2 | 27 participants (Anticipated) | Interventional | 2023-07-15 | Not yet recruiting | ||
| A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors[NCT00001579] | Phase 1 | 50 participants | Interventional | 1997-06-30 | Completed | ||
| Phase I Trial of Dose Escalated IMRT to the Para-aortic Nodes With Concurrent Cisplatin and Amifostine in Locally Advanced Cervical Cancer[NCT00137358] | Phase 1 | 0 participants (Actual) | Interventional | Withdrawn (stopped due to unable to obtain funding to conduct study) | |||
| Phase III Study Comparing Neoadjuvant Chemotherapy With Carboplatin and Paclitaxel Followed by Standard Therapy, With Standard Therapy Alone in Women With Cervical Cancer and Para Aortic Positive Lymph Node.[NCT03534713] | Phase 3 | 310 participants (Anticipated) | Interventional | 2020-07-17 | Recruiting | ||
| Phase II Randomized Controlled Trial of Concomitant Chemoradiotherapy With Standard Fractionation Compared to Hypofractionated Concomitant Chemoradiotherapy Followed by Brachytherapy, for Clinical Stage III Cervical Cancer Patients[NCT04070976] | 82 participants (Anticipated) | Interventional | 2019-07-01 | Recruiting | |||
| CRP on Radiobiological and Clinical Studies on Viral-induced Cancer's Response to Radiotherapy With Comprehensive Morbidity Assessment[NCT00122772] | Phase 3 | 601 participants (Actual) | Interventional | 2005-11-30 | Completed | ||
| A Phase III Randomized Clinical Trial to Study the Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Uterine Cervix.[NCT03256916] | Phase 3 | 348 participants (Anticipated) | Interventional | 2018-01-16 | Recruiting | ||
| Phase II Trial To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix[NCT04789941] | Phase 2 | 50 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | ||
| Effect of Neoadjuvant Cisplatin Based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: Clinical Outcome and Correlation to Biological Parameters[NCT00603408] | Phase 2 | 5 participants (Actual) | Interventional | 2007-12-31 | Terminated (stopped due to Study was discontinued due to lack of accrual.) | ||
| Study on Adaptive Radiotherapy and Multimodal Information of Cervical Cancer Assisted by Artificial Intelligence[NCT04022018] | 122 participants (Anticipated) | Interventional | 2019-12-18 | Recruiting | |||
| Effect of a Low Residue Diet in Comparison to the Dietary Recommendations From the INCan: A Randomized Clinical Trial to Assess Malnutrition, Gastrointestinal Toxicity and Quality of Life of Advanced Cervical Cancer Patients (IB2-IVA)[NCT03100409] | 137 participants (Actual) | Interventional | 2017-02-01 | Terminated (stopped due to The study was closed prematurely because the interim analysis found that subjects in the experimental group had less gastrointestinal toxicity.) | |||
| A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons[NCT02437851] | Phase 2 | 16 participants (Actual) | Interventional | 2015-04-30 | Active, not recruiting | ||
| Comparison of Tomotherapy Versus Intensity-modulated Step-and-shoot and Conventional Radiation Treatment Plans for Patients With Locally-advanced Squamous Cell Carcinoma of the Cervix[NCT00124488] | 10 participants | Observational | 2005-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The descriptions and grading scales found in the revised NCI Common Terminology Criteria for Adverse Events (CTCAE) version 3.0 will be utilized for all toxicity reporting. All detailed information regarding serious and other adverse events are listed in the Adverse Event module of these results. (NCT00603408)
Timeframe: 30 days post surgery (week 17-18)
| Intervention | participants (Number) |
|---|---|
| Cisplatin + Radiation + Recommended Surgery | 5 |
(NCT00603408)
Timeframe: 30 days post surgery (week 17-18)
| Intervention | participants (Number) |
|---|---|
| Cisplatin + Radiation + Recommended Surgery | 0 |
OS = Time from registration until death from any cause (NCT00603408)
Timeframe: Until study was terminated (23.5 months)
| Intervention | percentage of participants (Number) |
|---|---|
| Cisplatin + Radiation + Recommended Surgery | 100 |
"Complete response: disappearance of all target lesions, non-target lesions, and normalization of tumor marker level~Partial response: at least a 30% decrease in the sum of the longest diameter (LD) of the target lesions taking as reference the baseline sum LD~Stable disease: neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD taking as references the smallest sum LD since the treatment started,~Progressive disease: at least a 20% increase in the sum of the LD of the target lesions taking as reference the smallest sum LD recorded since the treatment started or the appearance of one or more new lesions, appearance of one more new lesions, or unequivocal progression of existing non-target lesions." (NCT00603408)
Timeframe: At the time of surgery (week 13)
| Intervention | participants (Number) | |||
|---|---|---|---|---|
| Complete response | Partial response | Stable disease | Progressive disease | |
| Cisplatin + Radiation + Recommended Surgery | 2 | 3 | 0 | 0 |
39 reviews available for fluorouracil and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
[Chemoradiotherapy for locally advanced cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cisp | 2014 |
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin | 2014 |
Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Fluoroura | 2016 |
[Primary clear cell carcinoma of the cervix: report of five cases and review of the literature].
Topics: Adenocarcinoma, Clear Cell; Adult; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; C | 2008 |
Combined chemotherapy and radiation therapy for cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Comb | 2004 |
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2010 |
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2010 |
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2010 |
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2010 |
Atypical metastatic carcinoid of the uterine cervix and review of the literature.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Chemo | 2011 |
Adjuvant platinum-based chemotherapy for early stage cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Fluoroura | 2012 |
[CHEMOTHERAPY OF UTERINE CERVIX CARCINOMA].
Topics: Antineoplastic Agents; Azaguanine; Aziridines; Chemotherapy, Cancer, Regional Perfusion; Cyclophosph | 1964 |
Current research directions for locally advanced cervix cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease Progre | 2003 |
[Taxol in advanced cervical cancer].
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemothe | 2004 |
Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Epirubicin; Fema | 2006 |
Cervical screening and management of cervical intraepithelial neoplasia in HIV-positive women.
Topics: Antiretroviral Therapy, Highly Active; Female; Fluorouracil; Follow-Up Studies; Forecasting; HIV Inf | 2006 |
[Sarcoma of the uterus].
Topics: Adolescent; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorour | 1982 |
[Simultaneous radiotherapy and chemotherapy in the treatment of advanced cancer of the cervix uteri].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Moda | 1993 |
Squamous cell carcinoma of the cervix implanting in the episiotomy site.
Topics: Adult; Carcinoma, Squamous Cell; Cicatrix; Cisplatin; Doxorubicin; Episiotomy; Female; Fluorouracil; | 1993 |
Locally advanced cervical carcinoma: the role of chemoradiation.
Topics: Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Human | 1994 |
Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma; Combined Modality Therapy; | 1996 |
[Clinical evaluation of chemoradiotherapy for advanced cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug | 1997 |
Paclitaxel pharmacology and other tumor types.
Topics: Alkylating Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols | 1997 |
[Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic | 1999 |
[Gynecologic cancer-evidenced based chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Evidence-Based Medicine; Femal | 2000 |
Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Comb | 2000 |
Chemoradiation for carcinoma of the cervix: advances and opportunities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, A | 2000 |
[Concomitant radiochemotherapy in cancer of the cervix uteri: modifications of the standards].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; | 2000 |
Current management of patients with invasive cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; | 2001 |
Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop | 2001 |
[Recent advances in intraarterial chemotherapy in gynecologic malignancy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoembolization, Therapeutic; Cisplatin | 2002 |
[Recommendations of GESIDA/Spanish National Plan of AIDS on diagnosis and treatment of Kaposi's sarcoma and cervical cancer in HIV-infected patients].
Topics: Acquired Immunodeficiency Syndrome; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agen | 2002 |
Advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modali | 2000 |
The integration of chemotherapy into combined modality treatment of solid tumors. VIII. Cervical cancer.
Topics: Alkylating Agents; Altretamine; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Drug Therapy, Co | 1977 |
Genital warts--therapy.
Topics: Condylomata Acuminata; Cryosurgery; Female; Fluorouracil; Humans; Laser Therapy; Male; Papillomaviri | 1992 |
Concurrent chemoradiation in carcinoma of the uterine cervix.
Topics: Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Hydroxyurea; Uterine Cervical Ne | 1992 |
Preventing cervical cancer by treating genital warts in men. Why male sex partners need androscopy.
Topics: Adult; Condylomata Acuminata; Cryosurgery; Desiccation; Female; Fluorouracil; Humans; Interferons; L | 1990 |
Concurrent chemoradiation in advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Hum | 1990 |
A review of lower genital intraepithelial neoplasia and the use of topical 5-fluorouracil.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Anal Canal; Anus Neoplasms; Carc | 1985 |
[Drug therapy of cervical cancer].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Chemotherapy, Cancer, Regional Perf | 1974 |
Current cancer chemotherapy in obstetrics and gynecology.
Topics: Alkaloids; Alkylating Agents; Anti-Bacterial Agents; Antimetabolites; Blood Cell Count; Bone Marrow; | 1971 |
Chemotherapy of squamous cell carcinoma of the cervix, vagina, and vulva.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Female; F | 1968 |
106 trials available for fluorouracil and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Hyst | 2017 |
Evaluation of Outcomes in Patients With Carcinoma of the Cervix Treated With Concurrent Radiation and Cisplatin Versus Cisplatin/5-FU Compared With Radiation Alone.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brac | 2015 |
Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial.
Topics: Administration, Intravaginal; Administration, Topical; Adolescent; Adult; Antimetabolites, Antineopl | 2014 |
[ATP-tumor chemosensitivity assay directed chemotherapy in patients with cervical cancer].
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisp | 2013 |
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2014 |
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma | 2014 |
Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluo | 2009 |
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dose | 2008 |
Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Fema | 2008 |
[Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherap | 2008 |
Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brachytherapy; Capecitabine; Carcinoma, Squamous Cell; | 2009 |
Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study.
Topics: Antimetabolites, Antineoplastic; Cisplatin; Drug Therapy, Combination; Female; Fluorouracil; Humans; | 2009 |
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2010 |
Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Disease Progression; Female; Fl | 2010 |
Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Agents; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Hu | 2011 |
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 2011 |
Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosq | 2011 |
Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Dist | 2011 |
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-F | 2012 |
Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration | 2002 |
Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B | 2003 |
First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 2003 |
[The modern organ- and function-sparing surgical treatment in oncology].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carci | 2003 |
Usefulness of preoperative chemoradiation in locally advanced cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 2004 |
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Brach | 2004 |
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Brach | 2004 |
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Brach | 2004 |
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Brach | 2004 |
Adjuvant oral 5-fluorouracil for cervical cancer: Japanese Gynecologic Oncology Group report.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Female; Fluorouracil; | 2004 |
[Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma; Cisplatin; Di | 2004 |
Concurrent chemotherapy and hypofractionated twice-daily radiotherapy in cervical cancer patients with stage IIIB disease and bilateral parametrial involvement: a phase I-II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2004 |
Neoadjuvant high-dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages IIIa-IVa cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusio | 2004 |
Report of an early stopped randomized trial comparing cisplatin vs. cisplatin/ifosfamide/ 5-fluorouracil in recurrent cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Ifosfamide; | 2005 |
[Chemoimmunoterapy in combination with radiotherapy for treatment of stage III B cervical cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2005 |
Feasibility of RNA collection for micro-array gene expression analysis in the treatment of cervical carcinoma: a scientific correlate of RTOG C-0128.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Celecoxib; Cisplatin; Combined Modali | 2005 |
Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; | 2005 |
Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; | 2005 |
[Comparison of therapeutical effect between arterial interventional chemotherapy and venous chemotherapy on bulky or locally advanced cervical cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Inje | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2006 |
Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer.
Topics: Adult; Antineoplastic Agents; Cisplatin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Ther | 2006 |
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; | 2007 |
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; | 2007 |
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; | 2007 |
Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; | 2007 |
A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Adeno | 2007 |
Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2007 |
Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2007 |
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2007 |
Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, | 2008 |
Are increased tumor aneuploidy and heightened cell proliferation along with heterogeneity associated with patient outcome for carcinomas of the uterine cervix? A combined analysis of subjects treated in RTOG 9001 and a single-institution trial.
Topics: Adenocarcinoma; Adult; Aged; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, | 2008 |
Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Moda | 2008 |
A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Cisplatin; Deo | 2007 |
Treatment of recurrent and metastatic carcinoma of the cervix: comparison of doxorubicin with a combination of vincristine and 5-fluorouracil.
Topics: Carcinoma; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; H | 1981 |
Phase II study of cisplatin, 5-fluorouracil and interferon-alpha in recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Follow | 1995 |
Radio chemotherapy in carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Fe | 1995 |
Induction chemotherapy and irradiation in advanced carcinoma of the cervix.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined M | 1995 |
[Usefulness of adjuvant chemotherapy with antimetabolites for cervical invasive cancer].
Topics: Adenocarcinoma; Administration, Oral; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Female; Fluo | 1995 |
Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival.
Topics: CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemotherapy, Adjuvant; Combi | 1995 |
[5-FU concentrations in the blood and tumor tissue after 5'-DFUR or UFT administration in the patients with uterine cervical cancer].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; Fluoroura | 1995 |
Cisplatin, 5-fluorouracil, and ifosfamide in the treatment of recurrent or advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1995 |
A phase II trial of ifosfamide, 5-fluorouracil, and leucovorin in recurrent uterine cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Fluo | 1994 |
A feasibility study of 252Cf neutron brachytherapy, cisplatin + 5-FU chemo-adjuvant and accelerated hyperfractionated radiotherapy for advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Californium; Cisplatin; | 1994 |
[A multicenter cooperative study on supplementary chemotherapy of uterocervical cancer. The Kyushu UFT Study Group of Uterocervical Cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 1994 |
[Long-term administration of carmofur as a post-operative adjuvant chemotherapy for cervical adenocarcinoma. Cervical Adenocarcinoma Cooperative Research Association].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; | 1994 |
Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 1994 |
Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma; Combined Modality Therapy; | 1996 |
[Neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil) in the treatment of stage III cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, | 1995 |
Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; C | 1996 |
Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, | 1996 |
Concurrent 5-fluorouracil, daily low-dose cisplatin, and radiotherapy in stage IIIB cervical cancer. A phase II prospective study.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squa | 1996 |
Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality | 1996 |
A phase II trial of 5-fluorouracil and high-dose leucovorin in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Topics: Antidotes; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; | 1996 |
Concurrent chemo- and radiotherapy in patients with locally advanced carcinoma of the cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carbop | 1996 |
[Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent pelvic tumors with or without radiotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplati | 1996 |
A randomised controlled trial evaluating a novel cytotoxic drug delivery system for the treatment of cervical intraepithelial neoplasia.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Double-Blind Method; Drug Delivery Systems | 1997 |
Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplast | 1997 |
Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcin | 1997 |
[Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1997 |
Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 1997 |
A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Disease-Fre | 1998 |
[Pelvic wall recurrence of cervix carcinomas. Combined surgical-radio-chemotherapeutic procedure (CORCT)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; | 1998 |
Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free S | 1998 |
Phase I trial of concomitant chemoradiotherapy for cervical cancer and other advanced pelvic malignancies.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Brachytherapy; Carcinoma; Cisplatin; Combined | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 1999 |
Carboplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up.
Topics: Adult; Aged; Analysis of Variance; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 1998 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 1999 |
Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
Topics: Actuarial Analysis; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplas | 1999 |
Long-term follow-up of neoadjuvant cisplatin and 5-fluorouracil chemotherapy in bulky squamous cell carcinoma of the cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease | 1999 |
Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; | 1999 |
[Long-term results of comprehensive treatment for cervical cancer with poor prognosis].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisp | 1999 |
[Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 1999 |
Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial.
Topics: Administration, Intravaginal; Adult; Antimetabolites, Antineoplastic; CD4 Lymphocyte Count; Female; | 1999 |
[Radiotherapy for cervical cancer: a multi-institutional comparison].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; | 1999 |
Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2000 |
Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2000 |
Neoadjuvant chemotherapy using low-dose consecutive intraarterial infusions of cisplatin combined with 5-fluorouracil for locally advanced cervical adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid | 2001 |
Intraoperative electron beam radiotherapy during radical surgery for locally advanced and recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; E | 2001 |
5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 1992 |
Mitomycin-C/5-FU and radiation therapy for locally advanced uterine cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality T | 1991 |
Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell | 1991 |
Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Flu | 1991 |
[Efficacy of adjuvant chemotherapy in metastasizing cervix carcinoma. A pilot study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Fema | 1991 |
Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Moda | 1990 |
Concurrent chemoradiation in advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Fluorouracil; Hum | 1990 |
A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial.
Topics: Adult; Aged; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carcinom | 1990 |
Management of condyloma acuminatum.
Topics: Clinical Trials as Topic; Condylomata Acuminata; Cryosurgery; Electrocoagulation; Female; Fluorourac | 1985 |
[Intra-arterial chemotherapy with methotrexate and 5-fluorouracil in extensive locoregional recurrences of cervix cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Female; Fluorouracil; Huma | 1988 |
Prophylactic topical 5-fluorouracil following treatment of human papillomavirus-associated lesions of the vulva and vagina.
Topics: Administration, Intravaginal; Administration, Topical; Carcinoma in Situ; Combined Modality Therapy; | 1986 |
Evaluation of 6,17 alpha-dimethyl-6-dehydroprogesterone for treatment of recurrent and metastatic gynecologic malignancy.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Drug | 1974 |
287 other studies available for fluorouracil and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Improved synthesis and antitumor activity of 1-deazaadenosine.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line; Female; HeLa Cells; Humans; Leu | 1987 |
Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma.
Topics: Binding Sites; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug De | 2014 |
Morphine stimulates cervical cancer cells and alleviates cytotoxicity of chemotherapeutic drugs via opioid receptor-dependent and -independent mechanisms.
Topics: Analgesics, Opioid; Cisplatin; ErbB Receptors; Female; Fluorouracil; Humans; Morphine; Paclitaxel; R | 2022 |
[A cervical cancer tissue-derived decellularized extracellular matrix scaffold for cervical cancer tissue reconstruction
Topics: Carcinoma; Decellularized Extracellular Matrix; Extracellular Matrix; Female; Fluorouracil; Humans; | 2023 |
In Vitro Prototyping of a Nano-Organogel for Thermo-Sonic Intra-Cervical Delivery of 5-Fluorouracil-Loaded Solid Lipid Nanoparticles for Cervical Cancer.
Topics: Female; Fluorouracil; Humans; Polyesters; Spectroscopy, Fourier Transform Infrared; Uterine Cervical | 2023 |
Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Topics: Adult; Feasibility Studies; Female; Fluorouracil; Humans; Imiquimod; Papillomaviridae; Papillomaviru | 2023 |
Crinamine Induces Apoptosis and Inhibits Proliferation, Migration, and Angiogenesis in Cervical Cancer SiHa Cells.
Topics: Amaryllidaceae Alkaloids; Angiogenesis Inhibitors; Animals; Carboplatin; Cell Line, Tumor; Cell Move | 2019 |
[Effects of Renal Function Evaluation with or without Serum Creatinine Adjustment on Cisplatin/Fluorouracil Therapy for Cervical Cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemoradiotherapy; Cisplati | 2019 |
Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Ch | 2022 |
Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
Topics: Antimetabolites, Antineoplastic; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression Re | 2021 |
Synergistic Cytotoxicity Effect of 5-Fluorouracil and SHP2 Inhibitor Demethylincisterol A3 on Cervical Cancer Cell.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Fluo | 2022 |
Enhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Proliferation; Drug Synergism; Female; Fluorouracil | 2017 |
Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carbopla | 2017 |
Topical 5-Fluorouracil for Women With High-Grade Vaginal Intraepithelial Neoplasia.
Topics: Administration, Intravaginal; Antimetabolites, Antineoplastic; Dissection; Female; Fluorouracil; Hum | 2017 |
ERCC1 expression status predicts the response and survival of patients with metastatic or recurrent cervical cancer treated via platinum-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2017 |
Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cells, | 2018 |
Percutaneous nerve electrical stimulation for fatigue caused by chemotherapy for cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Fat | 2018 |
Expression of Micro-RNA-492 (MiR-492) in Human Cervical Cancer Cell Lines is Upregulated by Transfection with Wild-Type P53, Irradiation, and 5-Fluorouracil Treatment In Vitro.
Topics: Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neopl | 2018 |
Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
Topics: ADAM17 Protein; Cell Adhesion Molecules; Cell Line, Tumor; Cell Nucleus; DNA Repair; Down-Regulation | 2019 |
Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Recepto | 2019 |
Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells.
Topics: Antineoplastic Agents; Apoptosis; beta Catenin; Cell Proliferation; Curcumin; Down-Regulation; Enzym | 2019 |
Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carb | 2013 |
Anticancer effects of the engineered stem cells transduced with therapeutic genes via a selective tumor tropism caused by vascular endothelial growth factor toward HeLa cervical cancer cells.
Topics: Bacterial Proteins; Cell Line; Cell Movement; Cell Survival; Coculture Techniques; Cytosine Deaminas | 2013 |
Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carcinoma, Squ | 2013 |
Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinom | 2013 |
Advanced carcinoma of the cervix in a 17-year-old girl.
Topics: Adolescent; Antineoplastic Agents; Carcinoma, Squamous Cell; Cervix Uteri; Cisplatin; Fatal Outcome; | 2013 |
Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradi | 2013 |
Prospective study of symptom assessment among patients with cervical cancer during concurrent chemoradiotherapy with weekly cisplatin or every-3-week cisplatin and 5-fluorouracil.
Topics: Adult; Aged; Anorexia; Antimetabolites, Antineoplastic; Anxiety; Carcinoma; Chemoradiotherapy; Cispl | 2013 |
ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Proliferatio | 2014 |
[Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiothe | 2013 |
[The significance of physical status of human papillomavirus type 16 for predicting the effectiveness of invasive cervical cancer treatment].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Comparative Effectiv | 2013 |
Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Disea | 2014 |
Fat composition changes in bone marrow during chemotherapy and radiation therapy.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Co | 2014 |
[Neoadjuvant chemoradiotherapy in the combined treatment of patients with stage IB2-III cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Cispla | 2014 |
Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Car | 2014 |
Chemopreventive potential of alpha lipoic acid in the treatment of colon and cervix cancer cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Caco-2 Cells; Cell Proliferation; Chem | 2014 |
Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of JAK1/STAT3 in the cervical carcinoma cell line C33A.
Topics: Antimetabolites, Antineoplastic; Carcinoma; Cell Division; Cell Line, Tumor; Cell Movement; Drug Res | 2015 |
Feasibility and Safety of Negative-Balance Isolated Pelvic Perfusion in Patients with Pretreated Recurrent or Persistent Uterine Cervical Cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 2015 |
Aldehyde Dehydrogenase 1 Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemotherapy Prior to Radical Hysterectomy.
Topics: Adult; Aldehyde Dehydrogenase 1 Family; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, | 2016 |
Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiothe | 2015 |
[Induction chemotherapy for locally advanced cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuva | 2015 |
Reconsideration of postoperative concurrent chemoradiotherapy with fluorouracil and cisplatin for uterine cervical cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; | 2015 |
Perianal infection of highly oncogenic human papilloma virus: how to prevent from cancer? Case report.
Topics: Anal Canal; Anus Neoplasms; Drug Administration Schedule; Female; Fluorouracil; Hemorrhoidectomy; He | 2015 |
Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Comorbidity; Female; Fluorouracil; Humans; Middle A | 2015 |
[Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 2016 |
Survival Outcomes of Advanced and Recurrent Cervical Cancer Patients Treated with Chemotherapy: Experience of Northern Tertiary Care Hospital in Thailand.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Fe | 2016 |
Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Dr | 2016 |
[Progress on clinical application of bevacizumab for the treatment of refractory cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cost-Benefit Analysis; Female; Fluorour | 2016 |
Assessment of anti-cancerous potential of 6-gingerol (Tongling White Ginger) and its synergy with drugs on human cervical adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Caspase 3; Catechols; Cell Cycle Checkpoints; Cell | 2017 |
Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; | 2008 |
XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Ci | 2008 |
[Comparison of effectiveness between intra-arterial and intra-venous neoadjuvant chemotherapy in stage Ib2-IIb cervical carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Fe | 2008 |
[Analysis of the diagnosis and treatment of cervical minimal deviation adenocarcinoma].
Topics: Actins; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryoni | 2008 |
High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carc | 2009 |
High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
Topics: Adenocarcinoma; Antineoplastic Agents; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Female; F | 2009 |
Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Assoc | 2009 |
Metastasis at the site of a venous needle puncture in a patient with advanced cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality The | 2009 |
Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Case-Control Studies; Cispla | 2009 |
The prognostic value of TRAIL and its death receptors in cervical cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Cyt | 2009 |
Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; B | 2010 |
Docetaxel, carboplatin and 5-fluorouracil (TCF) chemotherapy in patients with unresectable metastatic carcinoma of cervix.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Fluorouracil; | 2010 |
Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carci | 2010 |
Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Ci | 2010 |
Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carboplatin; Cisplatin; Confid | 2011 |
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Comb | 2010 |
Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adj | 2011 |
[Clinical value of the comprehensive treatment in intermediate and advanced cervical cancer with uterine arterial interventional chemoembolization and radiotherapy].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2010 |
A matched-case comparison to explore the role of consolidation chemotherapy after concurrent chemoradiation in cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Consolida | 2011 |
Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Th | 2011 |
Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 2011 |
Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Sq | 2011 |
Rhein lysinate induced S-phase arrest and increased the anti-tumor activity of 5-FU in HeLa cells.
Topics: Anthraquinones; Antineoplastic Agents, Phytogenic; Cell Division; Cell Line; Cyclin-Dependent Kinase | 2011 |
20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Cisplatin; | 2012 |
Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brac | 2012 |
Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Com | 2012 |
Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 2012 |
Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cel | 2012 |
The clinical characteristic differences between thrombosis-related edema and lymphedema following radiotherapy or chemoradiotherapy for patients with cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy | 2012 |
Effects of Agaricus blazei Murill extract on sensitivity to chemotherapeutic agents in HeLa cells and its resistant sublines.
Topics: Agaricus; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological | 2008 |
The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Chemoradiother | 2012 |
Outcomes and prognostic factors of cervical cancer after concurrent chemoradiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocol | 2012 |
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; | 2013 |
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Disease-Free Su | 2013 |
HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherap | 2012 |
Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiot | 2012 |
[Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 2012 |
Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; C | 2013 |
[Topical 5-fluorouracil for treatment of vaginal intraepithelial neoplasms].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Female; Fluorouracil; Humans; Middl | 2002 |
[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Comb | 2002 |
Cytotoxicity of combinations of IFN-beta and chemotherapeutic drugs.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Ce | 2002 |
The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours.
Topics: Antineoplastic Agents; Cell Survival; Cells, Cultured; Cisplatin; Drug Resistance, Neoplasm; Drug Sc | 2003 |
Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcino | 2003 |
Apoptosis, 5-fluorouracil sensitivity and expression of apoptotic proteins in a human ectocervical cell carcinogenesis model using different media.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Line, Transforme | 2003 |
Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells.
Topics: Antimetabolites, Antineoplastic; Cell Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Gen | 2003 |
Effect of 5-fluorouracil and epidermal growth factor on cell growth and dihydropyrimidine dehydrogenase regulation in human uterine cervical carcinoma SKG-IIIb cells.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Division; Dihydrouracil Dehydrogenas | 2003 |
CHEMOTHERAPY OF METASTATIC LIVER CANCER BY PROLONGED HEPATIC-ARTERY INFUSION.
Topics: Alkaline Phosphatase; Bile Duct Neoplasms; Bilirubin; Chemotherapy, Cancer, Regional Perfusion; Colo | 1964 |
PRELIMINARY OBSERVATIONS ON CARCINOMA OF THE CERVIX TREATED WITH 5-FLUOROURACIL.
Topics: Carcinoma; Female; Fluorouracil; Humans; Injections, Intravenous; Mortality; Neoplasms; Stomatitis; | 1964 |
VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Bronchogenic; Carcinoma, Squamous | 1964 |
EFFECTS OF IONIZING IRRADIATION AND CHEMOTHERAPEUTIC AGENTS ON HUMAN CHROMOSOMES.
Topics: Antineoplastic Agents; Biomedical Research; Chlorambucil; Choriocarcinoma; Chromosome Aberrations; C | 1964 |
A REPORT OF THE SYSTEMIC USE OF 5-FLUOROURACIL IN THE TREATMENT OF CHINESE CANCER PATIENTS.
Topics: Adenocarcinoma; Aged; Breast Neoplasms; Carcinoma; Carcinoma, Squamous Cell; China; Fallopian Tube N | 1964 |
[PRESENT POSSIBILITIES OF CHEMOPROPHYLAXIS, COMPLEMENTARY AND PALLIATIVE CHEMOTHERAPY IN ASSOCIATION WITH SURGERY IN THE TREATMENT OF UTERINE NEOPLASMS].
Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Chemoprevention; Female; Fluorouracil; Humans; Mi | 1964 |
REGIONAL INTRA-ARTERIAL INFUSION OF 5-FLUOROURACIL FOR CANCER.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Carcinoma, Squamous Cell; Female; Fluorouracil; Glioblast | 1964 |
A LESS TOXIC FLUOROURACIL DOSAGE SCHEDULE.
Topics: Alopecia; Breast Neoplasms; Colonic Neoplasms; Diarrhea; Drug Eruptions; Epistaxis; Female; Floxurid | 1964 |
COMBINED INTRA-ARTERIAL CHEMOTHERAPY AND RADIATION TREATMENT FOR ADVANCED CERVICAL CARCINOMA. THE MCCALL TECHNIQUE AND RESULTS.
Topics: Chemotherapy, Cancer, Regional Perfusion; Drug Therapy; Drug Therapy, Combination; Female; Fluoroura | 1965 |
CLOSED PELVIC PERFUSION IN ADVANCED GYNECOLOGIC CANCER.
Topics: Catheterization; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Female; Fluorouracil; F | 1965 |
CLOSED PELVIC PERFUSION: A NEW APPROACH TO THE PROBLEM OF ADVANCED GYNECOLOGIC MALIGNANCY.
Topics: Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Drug Therapy; Female; Fluorouracil; Geni | 1965 |
EGFR, ErbB2 and Ras but not Src suppress RhoB expression while ectopic expression of RhoB antagonizes oncogene-mediated transformation.
Topics: Animals; Anoikis; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Transformation, | 2004 |
Chemotherapy for recurrent or persistent cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Cisplatin; Clinical Tria | 2004 |
Concomitant radiochemotherapy plus surgery in locally advanced cervical cancer: update of clinical outcome and cyclooxygenase-2 as predictor of treatment susceptibility.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2004 |
Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells.
Topics: Antimetabolites, Antineoplastic; Base Sequence; Cell Division; DNA Primers; Electrophoresis, Gel, Tw | 2004 |
Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Fr | 2005 |
Radiotherapy for uterine cervical cancer: results of the 1995-1997 patterns of care process survey in Japan.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 2005 |
A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Carcinoma, | 2005 |
Cellular response to chemotherapy and radiation in cervical cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line | 2005 |
Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; An | 2005 |
Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Carboplatin; Cispla | 2005 |
Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D | 2006 |
Chemoradiotherapy for cervical cancer: what next?
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Survival | 2005 |
Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
Topics: Antigens, CD20; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; CD40 Anti | 2006 |
[Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2006 |
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2006 |
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2006 |
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2006 |
Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl | 2006 |
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Surviva | 2006 |
Management of multicentric lesions of the lower genital tract.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Cryosurgery; Female; Fluorouracil; Humans; | 2007 |
[Improvement of postoperative radiotherapy in the complex treatment of stage II-III cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; | 2006 |
Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
Topics: Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; | 2006 |
Effective chemoradiotherapy protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitro.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Survival; Female; Flap Endonucleases | 2006 |
Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined M | 2006 |
Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, | 2007 |
Bilateral avascular necrosis of the hips after chemoradiotherapy for cervical cancer.
Topics: Adult; Antineoplastic Agents; Capecitabine; Cisplatin; Deoxycytidine; Female; Femur Head Necrosis; F | 2006 |
Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Biological Assay; Bone Neoplasms; Brain Neoplasms; Breas | 2006 |
Expression of class III beta tubulin in cervical cancer patients administered preoperative radiochemotherapy: correlation with response to treatment and clinical outcome.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; C | 2007 |
[Role of cytological technique in the evaluation of the efficiency of intraarterial combined chemotherapy in patients with uterine cervical neoplasms].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytological Techniques; Doxo | 2006 |
Unexpected long-term survival without evidence of disease after salvage chemotherapy for recurrent metastatic cervical cancer: a case series.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease- | 2007 |
[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Topics: Adult; Antineoplastic Agents; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Cells | 2007 |
5-Fluorouracil cardiotoxicity complicating treatment of stage IIB cervical cancer--case report.
Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cardiac Output, Low | 2007 |
The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2007 |
Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinom | 2007 |
Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; | 2007 |
[Efficiency and side effects of concurrent radiotherapy and chemotherapy for advanced cervical cancers].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2007 |
[Retrospective study of chemoradiotherapy based on cisplatin compared with radiotherapy alone for cervical cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous | 2007 |
Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy | 2008 |
Intra-arterial chemotherapy in advanced pelvic tumors.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Injections, Int | 1967 |
Preparation and phase II clinical examination of topical dosage forms for the treatment of carcinoma colli containing bleomycin, carboquone, or 5-fluorouracil with hydroxypropyl cellulose.
Topics: Acrylic Resins; Administration, Topical; Antineoplastic Agents; Azirines; Bleomycin; Carbazilquinone | 1980 |
Local therapy of carcinoma of the uterine cervix: part I.
Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Bleomycin; Carbazilquinone; Drug Admini | 1981 |
[Chemotherapy of cervical cancer].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Admini | 1982 |
Recurrent cervical cancer in the pelvis--intra-arterial infusion of oncostatics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheterization; Cisplatin; Combined Moda | 1983 |
[Potentiation of cytotoxic effects of 5-fluorouracil by inosiplex on cancer cells].
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Cell Survival; Drug Synergism; Female; Fluorouraci | 1984 |
Intra-arterial infusion in tumors of the pelvis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality T | 1983 |
[Preoperative treatment of FT-207 suppository in cervical cancer-- serum and tumor tissue content of FT-207].
Topics: Cervix Uteri; Female; Fluorouracil; Humans; Suppositories; Tegafur; Uterine Cervical Neoplasms | 1984 |
[Clinical studies of kallidinogenase in combined chemotherapy for cervical cancer].
Topics: Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Kallikreins; Tegafur; Uteri | 1983 |
[Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (I) Pharmacokinetics in single administration at a dose of 1 gram].
Topics: Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Kinetics; Rectum; Suppositories; Tegafur; Ut | 1984 |
[Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (II) Pharmacokinetics in continuous administration at a daily dose of 1 gram].
Topics: Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Fluorouracil; Humans; Kinetics; Lymp | 1984 |
Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study.
Topics: Antibiotics, Antineoplastic; Brachytherapy; Carcinoma, Squamous Cell; Cesium Radioisotopes; Combined | 1984 |
[Pharmacokinetics of vaginal suppository FT-207 in uterine cervical cancer and radiation therapy].
Topics: Combined Modality Therapy; Female; Fluorouracil; Humans; Kinetics; Middle Aged; Suppositories; Tegaf | 1984 |
[Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female | 1984 |
[Fundamental studies on the introduction of chemotherapy of uterine cervical carcinoma--tissue level of 5-FU after oral administration].
Topics: Administration, Oral; Cervix Uteri; Female; Fluorouracil; Humans; Lymph Nodes; Ovary; Uterine Cervic | 1984 |
New possibilities of cytostatic drug testing on patient tumor cells by flow cytometry.
Topics: Antineoplastic Agents; Ascitic Fluid; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; D | 1984 |
Concentrations of a new antitumor agent, 1-hexylcarbamoyl-5-fluorouracil in serum and gynecologic tumor tissue.
Topics: Antineoplastic Agents; Female; Fluorouracil; Humans; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1983 |
Vaginal intraepithelial neoplasia: Biologic aspects and treatment with topical 5-fluorouracil and the carbon dioxide laser.
Topics: Adult; Aged; Carbon Dioxide; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Fluorouracil; Huma | 1980 |
[FT-207 maintenance therapy of malignant gynecologic cancer].
Topics: Antineoplastic Agents; Female; Fluorouracil; Humans; Middle Aged; Tegafur; Time Factors; Uterine Cer | 1982 |
[Clinical evaluation of Tegafur suppository in the treatment of uterine cancer--with special reference to the drug concentration in the blood, secretion from the pelvic dead space, and tissues of female genital organs].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorouracil; Genita | 1982 |
Four-drug combination chemotherapy for advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Drug Th | 1982 |
Topical 5-fluorouracil treatment of transformation zone intraepithelial neoplasia of cervix and vagina.
Topics: Administration, Topical; Carcinoma in Situ; Female; Fluorouracil; Humans; Uterine Cervical Dysplasia | 1982 |
Combination chemotherapy in advanced carcinoma of the cervix.
Topics: Alopecia; Antineoplastic Agents; Carcinoma; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Hum | 1982 |
Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro.
Topics: Adenocarcinoma; Cell Line; Cell Survival; Clone Cells; Colonic Neoplasms; Dose-Response Relationship | 1982 |
[Experimental chemotherapy. II: Study of the cytomorphologic effects of radiation and antitumor chemotherapy on neoplastic tissue].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chick Embryo; Culture Techniques; Cyclophosphamide; | 1980 |
Treatment of vaginal dysplasia and carcinoma in situ with topical 5-fluorouracil.
Topics: Adult; Aged; Carcinoma in Situ; Female; Fluorouracil; Humans; Middle Aged; Neoplasms, Multiple Prima | 1980 |
[Use of 5-fluorouracil in the radiation therapy of cervical cancer].
Topics: Adult; Aged; Cell Cycle; Cell Transformation, Neoplastic; Female; Fluorouracil; Humans; Lymphatic Me | 1980 |
Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Female | 1994 |
[Simultaneous radiochemotherapy in locally advanced cancers of the cervix: a preliminary study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; | 1995 |
Liquid scintillation spectrometry of 5-fluorouracil in cervical tissue following in vitro surface application of a bioadhesive cervical patch.
Topics: Adhesives; Cervix Uteri; Drug Delivery Systems; Female; Fluorouracil; Humans; Scintillation Counting | 1994 |
[A case of meningeal carcinomatosis which occurred after treatment for recurrence of the cervical carcinoma].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combine | 1995 |
5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation.
Topics: Acute Disease; Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Lip Ne | 1994 |
Prevention of 5 fluorouracil associated cardiotoxicity.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Female; Fluorouracil; Heart; Humans; Powders; Uterin | 1994 |
Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality | 1994 |
[Operation combined with chemotherapy for 63 cases of cervical carcinoma in the Xinjiang Kashi area].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuv | 1993 |
[Genital papillomavirus infection. A diagnostic and therapeutic dilemma].
Topics: Adult; Condylomata Acuminata; Diagnosis, Differential; Female; Fluorouracil; Humans; Male; Papilloma | 1993 |
Combined chemotherapy and radiation for bulky stages I-II cervical cancer: comparison of concurrent and sequential regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, A | 1993 |
Neoadjuvant and salvage chemotherapy with cisplatin (CDDP) and 5-fluorouracil (5-FU) in cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcino | 1993 |
[Three cases of uterine cervical adenocarcinoma successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil)].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cispl | 1996 |
High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Sq | 1996 |
[Effect of preoperative oral 5-fluorouracil on cell cycle of advanced cervical squamous cell carcinoma].
Topics: Administration, Oral; Adult; Carcinoma, Squamous Cell; Cell Cycle; Chemotherapy, Adjuvant; Female; F | 1996 |
Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brac | 1995 |
[Results of adjuvant chemotherapy of operated high risk cervix carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 1996 |
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents.
Topics: Adenoviridae; Adenovirus E1B Proteins; Antigens, Viral; Capsid; Capsid Proteins; Cells, Cultured; Ch | 1997 |
Growth inhibition and apoptotic cell death in uterine cervical carcinoma cells induced by 5-fluorouracil.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Squamous | 1997 |
Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplas | 1997 |
[Evaluation of a new anti-cancer drug regimen against uterine cervical cancer in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Ca | 1997 |
Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Membe | 1998 |
[How toxic and effective is simultaneous radiochemotherapy with hydroxyurea, 5-FU and cisplatin in cervix carcinoma?].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chem | 1998 |
Time to add chemotherapy to radiotherapy for cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Clinical Trials, Phase III | 1999 |
Chemotherapy plus radiation improves survival in patients with cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 1999 |
Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; F | 1999 |
The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Transfusion; Carcinoma, | 1999 |
5-FU for cervical intraepithelia neoplasia.
Topics: Administration, Intravaginal; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Female; Fluor | 2000 |
Concurrent chemotherapy and radiotherapy in invasive cervical cancer patients with high risk factors.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, | 2000 |
The bulky 6-cm barrel-shaped lesion of the cervix: primary surgery and postoperative chemoradiation.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combine | 2000 |
[Postoperative simultaneous radiochemotherapy improves survival in patients with cervical carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Aden | 2000 |
Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Division; Dihydrouracil Dehydrogenas | 2000 |
Chemoradiotherapy: the new standard care for invasive cervical cancer.
Topics: Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Humans; Hydroxyur | 2000 |
[The contrast between chemotherapy via pelvic retroperitoneal cannulation and intraperitoneal chemotherapy in gynecological malignancies cancers with lymph node metastases].
Topics: Antimetabolites, Antineoplastic; Endometrial Neoplasms; Female; Fluorouracil; Humans; Injections, In | 1999 |
5-FU for maintenance therapy of cervical lesions.
Topics: Administration, Intravaginal; Antimetabolites, Antineoplastic; Female; Fluorouracil; HIV Infections; | 1999 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinom | 2001 |
Indomethacin increases the cytotoxicity of cis-platinum and 5-fluorouracil in the human uterine cervical cancer cell lines SKG-2 and HKUS by increasing the intracellular uptake of the agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cis | 2001 |
[Adjuvant simultaneous radiochemotherapy after operated uterine cervix carcinoma in high risk situation. Results of a pilot study].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined M | 2002 |
Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervical cancer: 12-Year survival after radiochemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2002 |
[Topical chemotherapy for carcinoma of the skin (author's transl)].
Topics: Administration, Topical; Adolescent; Aged; Bleomycin; Bowen's Disease; Carcinoma, Basal Cell; Carcin | 1975 |
Seven-drug polychemotherapy in the treatment of advanced and recurrent squamous carcinoma of the female genital tract.
Topics: Adult; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Dac | 1975 |
Letter: 5-F.U. or D. N.C.B. for non-clinical vaginal cancer.
Topics: Dinitrochlorobenzene; Female; Fluorouracil; Humans; Nitrobenzenes; Uterine Cervical Neoplasms; Vagin | 1976 |
Letter: 5-F.U. or D.N.C.B. for non-clinical vaginal and cervical cancer.
Topics: Carcinoma, Squamous Cell; Dinitrochlorobenzene; Drug Evaluation; Female; Fluorouracil; Humans; Nitro | 1976 |
Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vagina.
Topics: Adenocarcinoma; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cyclophosphamide; Dactin | 1978 |
Postirradiation squamous cell carcinoma in situ of the vagina: treatment by topical 20 percent 5-fluorouracil cream.
Topics: Administration, Topical; Adult; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Middle Aged; | 1979 |
[Endolymphatic chemotherapy of cervix neoplasms].
Topics: Antineoplastic Agents; Cyclophosphamide; Female; Fluorouracil; Humans; Infusions, Parenteral; Inject | 1976 |
Chemotherapy of carcinoma of the cervix.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Squamous Cel | 1977 |
[In vitro testing and clinical experience with 5-fluorouracil in gynaecologic cancer (author's transl)].
Topics: Adult; Aged; Culture Techniques; Drug Evaluation; Female; Fluorouracil; Genital Neoplasms, Female; H | 1976 |
Sequential MTX-5 FU chemotherapy in pallination of advanced cancer cervix.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 1992 |
Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cycl | 1992 |
Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervix.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intrav | 1992 |
A dual anti-tumor effect of a combination of interferon-alpha and 5-flurouracil or 2-chlorodeoxyadenosine on natural killer (NK) cell mediated cytotoxicity.
Topics: 2-Chloroadenosine; Acquired Immunodeficiency Syndrome; Antimetabolites, Antineoplastic; Cell Divisio | 1991 |
[Systemic therapy in recurrent and primary advanced cervix cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 1991 |
Radiation myelitis: a complication of concurrent cisplatin and 5-fluorouracil chemotherapy with extended field radiotherapy for carcinoma of the uterine cervix.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cis | 1991 |
[Initial results of adjuvant chemotherapy of operated cervix cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorou | 1991 |
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; | 1991 |
[Investigation of 5-fluorouracil (5-FU) levels and pyrimidine nucleoside phosphorylase activities in the tissues from patients with uterine cervical and ovarian cancers after oral administration of 5'-DFUR].
Topics: Administration, Oral; Antineoplastic Agents; Female; Floxuridine; Fluorouracil; Humans; Lymph Nodes; | 1991 |
[The conservative treatment of carcinoma in situ of the cervix uteri by the local application of 5-fluorouracil].
Topics: Administration, Topical; Adult; Biopsy; Carcinoma in Situ; Cervix Uteri; Colposcopy; Female; Fluorou | 1991 |
[A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Female; Fluor | 1990 |
Treatment of 29 patients with bulky squamous cell carcinoma of the cervix with simultaneous cisplatin, 5-fluorouracil, and split-course hyperfractionated radiation therapy.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; H | 1990 |
[Effects of urinastatin against nephrotoxicity of cisplatinum].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Urea Nitrogen; Cisplatin; Cyclophospham | 1990 |
[Effective continuous intraarterial chemotherapy for a patient with FIGO stage IIIb cervical adenocarcinoma invasing the bladder wall].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Hum | 1990 |
5-Fluorouracil neurotoxicity.
Topics: Adult; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Middle Aged; Nervous System Diseases; | 1990 |
A phase II study of 5-fluorouracil/cisplatinum in recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dr | 1990 |
Sequential intra-arterial chemotherapy plus irradiation in malignant gynecologic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cobalt Radioisotopes; Combined Modality Therapy; Dac | 1987 |
[Sensitivity of antineoplastic agents in squamous cell carcinoma of the uterine cervix xenografted into nude mice].
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Sc | 1987 |
The treatment of advanced recurrent carcinoma of the uterine cervix with platinum based cytotoxic chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Flu | 1987 |
Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1989 |
[Experimental study on the effect of UFT with concomitant radiotherapy of uterine cervical cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell | 1989 |
[The concentration of 5-fluorouracil in blood and tissues of the patients with carcinoma of the cervix after administration of UFT and 5-fluorouracil].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1989 |
[In vitro studies of 5-FU sensitivity on uterine cervical cancer cell lines--comparison between squamous cell carcinoma and adenocarcinoma].
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Survival; DNA, Neoplasm; Drug Screening Assays, Antit | 1989 |
Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B.
Topics: Amphotericin B; Animals; Antimetabolites, Antineoplastic; Dipyridamole; Drug Evaluation, Preclinical | 1989 |
Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cisp | 1989 |
A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dr | 1989 |
Use of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancer.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 1989 |
Genital condylomas in immunosuppressed women: a therapeutic challenge.
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Condylomata Acuminata; Female; Fluorouracil | 1986 |
[5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Sch | 1986 |
Clinical evidence of feasibility and efficacy of simultaneous irradiation and chemotherapy in advanced squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Brachytherapy; Carcinom | 1986 |
[In vitro effects of 5-FU on gynecologic malignant tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Line; Cells, Cultured; Colony-Fo | 1986 |
[Studies on oral-adjuvant chemotherapy of uterine cervical cancer after surgical treatment].
Topics: Adenocarcinoma; Administration, Oral; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Eval | 1986 |
Concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after radical surgery.
Topics: Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Mitomycin; Mitomyci | 1987 |
Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cesium Radi | 1987 |
[Isolation chemotherapy at the pelvic vascular bed in the management of advanced cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 1987 |
Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; | 1988 |
Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1988 |
Cisplatin and 5-fluorouracil in advanced and recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Female; Flu | 1988 |
[Intraarterial infusion of oncostasis in patients with advanced cervical adenocarcinoma--two case reports].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouraci | 1988 |
Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Fe | 1988 |
[Intraarterial infusion of oncostasis in patients with recurrent cervical cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female; F | 1988 |
[Multidisciplinary, intra-arterial chemotherapy (IAC) with CDDP and 5-FU against cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Moda | 1988 |
[Local treatment of cervical intraepithelial neoplasia with a 5 percent fluorouracil ointment].
Topics: Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cervix Uteri; Condylomata Acuminata; Female; Fl | 1987 |
[Value of initial chemotherapy in the treatment of advanced cancers of the uterine cervix].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubici | 1987 |
[Intra-arterial chemotherapy combined with surgery in the treatment of stage II cervical carcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality T | 1987 |
[Phase II study of 5-FU tablets in cancer of the uterine cervix].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Evaluation; Female; Fluoroura | 1987 |
Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; D | 1987 |
Treatment of recurrent carcinoma of the cervix with bromocriptine.
Topics: Adult; Aged; Bromocriptine; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Middle Aged; Neo | 1986 |
Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Topics: Adenocarcinoma; Altretamine; Anti-Mullerian Hormone; Ascitic Fluid; Carcinoma; Chromatography, Affin | 1985 |
[A study on plasma and tissue 5-FU concentrations in patients with cervical cancer treated with UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Tegafur; Uracil; Uteri | 1985 |
[Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cervix Ute | 1985 |
Early diagnosis and management of premalignant lesions and early invasive cancers of the vulva.
Topics: Adult; Aged; Carcinoma; Female; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metas | 1971 |
Lead-positive nuclear structures and their behavior under the effect of various drugs.
Topics: Adenosine; Cell Line; Cell Nucleolus; Cell Nucleus; Cycloheximide; Dactinomycin; Deoxyadenosines; Fe | 1972 |
Chemotherapy and hormone therapy in gynecologic cancer.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Choriocarcinoma; Dactinomycin; F | 1973 |
Experimental chemotherapy in carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dactinomycin; Drug Therapy, Combina | 1974 |
[Loco-regional and sequential chemotherapy of advanced cancer].
Topics: Adult; Carcinoma; Carcinoma, Hepatocellular; Chemotherapy, Cancer, Regional Perfusion; Dysgerminoma; | 1968 |
[Effects of 5-fluorouracil (5-FU) ointment on intraepithelial carcinoma of the cervix].
Topics: Administration, Topical; Adult; Carcinoma; Female; Fluorouracil; Humans; Middle Aged; Ointments; Ute | 1974 |
Prognosis of uterine cervical cancer with extensive lymph node metastases. Special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer.
Topics: Cobalt Isotopes; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Mitomycins; Postop | 1972 |
[Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
Topics: Antineoplastic Agents; Cyclophosphamide; Drug Resistance; Female; Fluorouracil; Genital Neoplasms, F | 1973 |
Gynecologic oncology.
Topics: Alkylating Agents; Ascites; Biopsy; Dactinomycin; Endometrium; Female; Fluorouracil; Genital Neoplas | 1973 |
Effect of 5-fluorouracil and actinomycin D on repair of DNA single-strand breaks in cervix cancer cells.
Topics: Carcinoma, Squamous Cell; Cell Division; Cell Line; Dactinomycin; DNA Repair; DNA, Neoplasm; Female; | 1973 |
Systemic chemotherapy for carcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Fema | 1967 |
[Regional chemotherapy in far advanced forms of cancer of the uterine cervix].
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Female; Fluoroura | 1969 |
Combined parenteral hyperalimentation and chemotherapy in the treatment of disseminated solid tumors.
Topics: Amino Acids; Analgesics; Appetite; Body Weight; Breast Neoplasms; Carcinoid Tumor; Colonic Neoplasms | 1971 |
Hypogastric artery infusion and radiation therapy for advanced squamous cell carcinoma of the cervix.
Topics: Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Injections, Intra-Arterial; Methods; Methotr | 1972 |
Hepatic artery ligation and cytotoxic infusion in treatment of liver metastases.
Topics: Aged; Alkaline Phosphatase; Female; Fluorouracil; Gallbladder Neoplasms; Hepatic Artery; Humans; Inj | 1972 |
Comments on morbidity in present-day radiotherapy.
Topics: Breast Neoplasms; Buttocks; Carcinoma, Squamous Cell; Dactinomycin; Erythema; Female; Fluorouracil; | 1971 |
A primary melanocarcinoma of the cervix.
Topics: Adult; Cervix Uteri; Female; Fluorouracil; Humans; Imidazoles; Melanoma; Melphalan; Neoplasm Metasta | 1971 |
Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Flu | 1971 |
Clinical immunologic responsiveness in malignant disease. I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs.
Topics: Adolescent; Adult; Aged; Antigens; Antineoplastic Agents; Breast Neoplasms; Candida; Child; Child, P | 1970 |
Combination of 5-fluorouracil and radiation as primary therapy of carcinoma of the cervix.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cobalt Isotopes; Female; Fluorouracil; Humans; Mesonephrom | 1968 |